10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549 

FORM 10-Q 

(Mark One)

☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended October 3, 2021 or

☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from __________ to __________

Commission File Number 001-34218

COGNEX CORPORATION

(Exact name of registrant as specified in its charter)

Massachusetts	04-2713778
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

One Vision Drive

Natick, Massachusetts 01760-2059

(508) 650-3000

(Address, including zip code, and telephone number, including area code, of principal executive offices)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $.002 per share	CGNX	The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act (Check one):

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    

Yes ☐ No ☒

As of October 3, 2021, there were 176,799,003 shares of Common Stock, $.002 par value per share, of the registrant outstanding.

INDEX

PART I	FINANCIAL INFORMATION	3
Item 1.	Financial Statements (interim periods unaudited)	3
	Consolidated Statements of Operations for the three-month and nine-month periods ended October 3, 2021 and September 27, 2020	3
	Consolidated Statements of Comprehensive Income for the three-month and nine-month periods ended October 3, 2021 and September 27, 2020	4
	Consolidated Balance Sheets as of October 3, 2021 and December 31, 2020	5
	Consolidated Statements of Cash Flows for the nine-month periods ended October 3, 2021 and September 27, 2020	6
	Consolidated Statements of Shareholders’ Equity for the three-month and nine-month periods ended October 3, 2021 and September 27, 2020	7
	Notes to Consolidated Financial Statements	9
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	25
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	30
Item 4.	Controls and Procedures	30
PART II	OTHER INFORMATION
Item 1.	Legal Proceedings	31
Item 1A.	Risk Factors	31
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	31
Item 3.	Defaults Upon Senior Securities	31
Item 4.	Mine Safety Disclosures	31
Item 5.	Other Information	31
Item 6.	Exhibits	32
	Signatures	33

2

PART I: FINANCIAL INFORMATION

ITEM 1: FINANCIAL STATEMENTS

COGNEX CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

	Three-months Ended				Nine-months Ended
	October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
	(unaudited)				(unaudited)
Revenue	$	284,848	$	251,073	$	793,033	$	587,405
Cost of revenue	85,712		59,741		208,189		151,261
Gross margin	199,136		191,332		584,844		436,144
Research, development, and engineering expenses	34,476		30,240		99,883		96,583
Selling, general, and administrative expenses	77,113		64,206		226,380		193,497
Restructuring charges (Note 16)	—		251		—		15,049
Intangible asset impairment charges (Note 8)	—		—		—		19,571
Operating income	87,547		96,635		258,581		111,444
Foreign currency gain (loss)	(586)		2,357		(2,233)		(310)
Investment income	1,748		2,490		5,025		11,010
Other income (expense)	(125)		(173)		(420)		(153)
Income before income tax expense	88,584		101,309		260,953		121,991
Income tax expense	9,684		13,803		34,607		15,150
Net income	$	78,900	$	87,506	$	226,346	$	106,841
Net income per weighted-average common and common-equivalent share:
Basic	$	0.45	$	0.50	$	1.28	$	0.62
Diluted	$	0.44	$	0.49	$	1.26	$	0.61
Weighted-average common and common-equivalent shares outstanding:
Basic	176,812		173,943		176,572		172,881
Diluted	180,342		177,138		180,109		176,038
Cash dividends per common share	$	0.060	$	0.055	$	0.180	$	0.165

The accompanying notes are an integral part of these consolidated financial statements.

3

COGNEX CORPORATION

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

	Three-months Ended				Nine-months Ended
	October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
	(unaudited)				(unaudited)
Net income	$	78,900	$	87,506	$	226,346	$	106,841
Other comprehensive income (loss), net of tax:
Available-for-sale investments:
Net unrealized gain (loss), net of tax of $(162) and $2,855 in the three-month periods and net of tax of $(808) and $1,067 in the nine-month periods, respectively	(521)		(2,308)		(2,617)		6,282
Reclassification of credit loss (recovery) on investments into current operations	—		—		—		75
Reclassification of net realized (gain) loss on the sale of available-for-sale investments into current operations	(19)		(786)		(87)		(3,591)
Net change related to available-for-sale investments	(540)		(3,094)		(2,704)		2,766
Foreign currency translation adjustments:
Foreign currency translation adjustments	(2,136)		2,098		(5,243)		(3,364)
Net change related to foreign currency translation adjustments	(2,136)		2,098		(5,243)		(3,364)
Other comprehensive income (loss), net of tax	(2,676)		(996)		(7,947)		(598)
Total comprehensive income	$	76,224	$	86,510	$	218,399	$	106,243

The accompanying notes are an integral part of these consolidated financial statements.

4

COGNEX CORPORATION

CONSOLIDATED BALANCE SHEETS

(In thousands)

	October 3, 2021		December 31, 2020
	(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	203,479	$	269,073
Current investments, amortized cost of $188,349 and $102,258 in 2021 and 2020, respectively, allowance for credit losses of $0 in 2021 and 2020	189,113		103,240
Accounts receivable, allowance for credit losses of $792 and $831 in 2021 and 2020, respectively	129,784		125,696
Unbilled revenue	7,325		5,632
Inventories	81,170		60,830
Prepaid expenses and other current assets	61,196		37,220
Total current assets	672,067		601,691
Non-current investments, amortized cost of $591,378 and $390,417 in 2021 and 2020, respectively, allowance for credit losses of $0 in 2021 and 2020	592,794		395,125
Property, plant, and equipment, net	76,882		79,173
Operating lease assets	24,154		22,582
Goodwill	241,799		244,078
Intangible assets, net	12,782		15,555
Deferred income taxes	420,962		434,704
Other assets	7,363		7,794
Total assets	$	2,048,803	$	1,800,702
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	26,797	$	16,270
Accrued expenses	80,337		77,264
Accrued income taxes	12,271		9,379
Deferred revenue and customer deposits	37,843		21,274
Operating lease liabilities	7,889		8,110
Total current liabilities	165,137		132,297
Non-current operating lease liabilities	18,922		18,120
Deferred income taxes	302,019		314,952
Reserve for income taxes	14,805		14,257
Non-current accrued income taxes	40,963		48,915
Other liabilities	13,996		9,959
Total liabilities	555,842		538,500
Shareholders’ equity:
Preferred stock, $.01 par value – Authorized: 400 shares in 2021 and 2020, respectively, no shares issued and outstanding	—		—
Common stock, $.002 par value – Authorized: 300,000 shares in 2021 and 2020, respectively, issued and outstanding: 176,799 and 175,790 shares in 2021 and 2020, respectively	354		352
Additional paid-in capital	900,190		807,739
Retained earnings	634,165		487,912
Accumulated other comprehensive loss, net of tax	(41,748)		(33,801)
Total shareholders’ equity	1,492,961		1,262,202
Total liabilities and shareholders' equity	$	2,048,803	$	1,800,702

The accompanying notes are an integral part of these consolidated financial statements.

5

COGNEX CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

	Nine-months Ended
	October 3, 2021		September 27, 2020
	(unaudited)
Cash flows from operating activities:
Net income	$	226,346	$	106,841
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	33,353		32,076
Depreciation of property, plant, and equipment	12,641		16,467
Loss on disposal of property, plant, and equipment	4		1,654
Amortization of intangible assets	2,773		3,437
Intangible asset impairment charges	—		19,571
Excess and obsolete inventory charges	2,120		9,386
Operating lease asset impairment charges	—		2,534
Amortization of discounts or premiums on investments	3,316		765
Realized gain on sale of investments	(87)		(3,591)
Credit loss on investments	—		75
Revaluation of contingent consideration	—		(114)
Change in deferred income taxes	1,411		3,194
Change in operating assets and liabilities:
Accounts receivable	(4,295)		(23,878)
Unbilled revenue	(1,689)		(10,606)
Inventories	(22,534)		(3,065)
Prepaid expenses and other current assets	(24,607)		(10,718)
Accounts payable	10,576		3,587
Accrued expenses	4,416		17,028
Accrued income taxes	(4,936)		(23,627)
Deferred revenue and customer deposits	16,751		19,066
Other	3,297		(632)
Net cash provided by operating activities	258,856		159,450
Cash flows from investing activities:
Purchases of investments	(607,458)		(601,447)
Maturities and sales of investments	317,174		567,245
Purchases of property, plant, and equipment	(10,689)		(9,829)
Net cash provided by (used in) investing activities	(300,973)		(44,031)
Cash flows from financing activities:
Net proceeds from issuance of common stock under stock plans	59,101		91,390
Repurchase of common stock	(48,294)		(51,036)
Payment of dividends	(31,800)		(28,554)
Payment of contingent consideration	—		(1,039)
Net cash provided by (used in) financing activities	(20,993)		10,761
Effect of foreign exchange rate changes on cash and cash equivalents	(2,484)		745
Net change in cash and cash equivalents	(65,594)		126,925
Cash and cash equivalents at beginning of period	269,073		171,431
Cash and cash equivalents at end of period	$	203,479	$	298,356

The accompanying notes are an integral part of these consolidated financial statements.

6

COGNEX CORPORATION

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(In thousands)

	Common Stock			Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Total Shareholders’ Equity
	Shares	Par Value
Balance as of July 4, 2021	176,707	$	353	$	874,883	$	593,290	$	(39,072)	$	1,429,454
Net issuance of common stock under stock plans	415	1		14,693		—		—		14,694
Repurchase of common stock	(323)	—		—		(27,417)		—		(27,417)
Stock-based compensation expense	—	—		10,614		—		—		10,614
Payment of dividends ($0.060 per common share)	—	—		—		(10,608)		—		(10,608)
Net income	—	—		—		78,900		—		78,900
Net unrealized gain (loss) on available-for-sale investments, net of tax of $(162)	—	—		—		—		(521)		(521)
Reclassification of net realized (gain) loss on the sale of available-for-sale investments	—	—		—		—		(19)		(19)
Foreign currency translation adjustment	—	—		—		—		(2,136)		(2,136)
Balance as of October 3, 2021 (unaudited)	176,799	$	354	$	900,190	$	634,165	$	(41,748)	$	1,492,961

	Common Stock			Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Total Shareholders’ Equity
	Shares	Par Value
Balance as of June 28, 2020	173,047	$	346	$	710,412	$	702,597	$	(36,877)	$	1,376,478
Net issuance of common stock under stock plans	1,586	3		43,152		—		—		43,155
Stock-based compensation expense	—	—		9,268		—		—		9,268
Payment of dividends ($0.055 per common share)	—	—		—		(9,582)		—		(9,582)
Net income	—	—		—		87,506		—		87,506
Net unrealized gain (loss) on available-for-sale investments, net of tax of $2,855	—	—		—		—		(2,308)		(2,308)
Reclassification of net realized (gain) loss on the sale of available-for-sale investments	—	—		—		—		(786)		(786)
Foreign currency translation adjustment	—	—		—		—		2,098		2,098
Balance as of September 27, 2020 (unaudited)	174,633	$	349	$	762,832	$	780,521	$	(37,873)	$	1,505,829

The accompanying notes are an integral part of these consolidated financial statements.

7

COGNEX CORPORATION

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(In thousands)

	Common Stock			Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Total Shareholders’ Equity
	Shares	Par Value
Balance as of December 31, 2020	175,790	$	352	$	807,739	$	487,912	$	(33,801)	$	1,262,202
Net issuance of common stock under stock plans	1,590	3		59,098		—		—		59,101
Repurchase of common stock	(581)	(1)		—		(48,293)		—		(48,294)
Stock-based compensation expense	—	—		33,353		—		—		33,353
Payment of dividends ($0.180 per common share)	—	—		—		(31,800)		—		(31,800)
Net income	—	—		—		226,346		—		226,346
Net unrealized gain (loss) on available-for-sale investments, net of tax of $(808)	—	—		—		—		(2,617)		(2,617)
Reclassification of net realized (gain) loss on the sale of available-for-sale investments	—	—		—		—		(87)		(87)
Foreign currency translation adjustment	—	—		—		—		(5,243)		(5,243)
Balance as of October 3, 2021 (unaudited)	176,799	$	354	$	900,190	$	634,165	$	(41,748)	$	1,492,961

	Common Stock			Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Total Shareholders’ Equity
	Shares	Par Value
Balance as of December 31, 2019	172,440	$	345	$	639,372	$	753,268	$	(37,275)	$	1,355,710
Net issuance of common stock under stock plans	3,408	6		91,384		—		—		91,390
Repurchase of common stock	(1,215)	(2)		—		(51,034)		—		(51,036)
Stock-based compensation expense	—	—		32,076		—		—		32,076
Payment of dividends ($0.165 per common share)	—	—		—		(28,554)		—		(28,554)
Net income	—	—		—		106,841		—		106,841
Net unrealized gain (loss) on available-for-sale investments, net of tax of $1,067	—	—		—		—		6,282		6,282
Reclassification of credit loss (recovery) on investments	—	—		—		—		75		75
Reclassification of net realized (gain) loss on the sale of available-for-sale investments	—	—		—		—		(3,591)		(3,591)
Foreign currency translation adjustment	—	—		—		—		(3,364)		(3,364)
Balance as of September 27, 2020 (unaudited)	174,633	$	349	$	762,832	$	780,521	$	(37,873)	$	1,505,829

The accompanying notes are an integral part of these consolidated financial statements.

8

COGNEX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 1: Summary of Significant Accounting Policies

As permitted by the rules of the Securities and Exchange Commission applicable to Quarterly Reports on Form 10-Q, these notes are condensed and do not contain all disclosures required by generally accepted accounting principles (GAAP). Reference should be made to the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 for a full description of other significant accounting policies.

In the opinion of the management of Cognex Corporation (the "Company"), the accompanying consolidated unaudited financial statements contain all adjustments, consisting of normal, recurring adjustments, excess and obsolete inventory charges (Note 5), intangible asset impairment charges (Note 8), restructuring charges (Note 16) and financial statement reclassifications necessary to present fairly the Company’s financial position as of October 3, 2021, and the results of its operations for the three-month and nine-month periods ended October 3, 2021 and September 27, 2020, and changes in shareholders’ equity, comprehensive income, and cash flows for the periods presented.

The results disclosed in the Consolidated Statements of Operations for the three-month and nine-month periods ended October 3, 2021 are not necessarily indicative of the results to be expected for the full year.

NOTE 2: New Pronouncements

Accounting Standards Update (ASU) 2019-12, "Simplifying the Accounting for Income Taxes"

The amendments in this ASU eliminate certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. They also clarify and simplify other aspects of the accounting for income taxes. The Company adopted ASU 2019-12 on January 1, 2021. Upon adoption, ASU 2019-12 did not have a material impact on the Company's consolidated financial statements and disclosures.

Accounting Standards Update (ASU) 2020-08, "Codification Improvements to Subtopic 310-20, Receivables - Nonrefundable Fees and Other Costs"

The amendments in this ASU clarify that for each reporting period, for callable debt with multiple call dates and call prices that may change at each call date, to the extent that the amortized cost basis of an individual callable debt security exceeds the amount repayable by the issuer at the next call date, the excess is amortized to the next call date. The Company adopted ASU 2020-08 on January 1, 2021. Upon adoption, ASU 2020-08 did not have a material impact on the Company's consolidated financial statements and disclosures.

Accounting Standards Update (ASU) 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting" and (ASU) 2021-01, "Reference Rate Reform (Topic 848): Scope"

The amendments in these ASUs apply to all entities that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. Together, the ASUs provide optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The expedients and exceptions provided by the amendments do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. The amendments in these ASUs are effective for all entities as of March 12, 2020 through December 31, 2022. Management does not expect ASU 2020-04 or ASU 2021-01 to have a material impact on the Company's consolidated financial statements and disclosures.

9

COGNEX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 3: Fair Value Measurements

Financial Assets and Liabilities that are Measured at Fair Value on a Recurring Basis

The following table summarizes the financial assets and liabilities required to be measured at fair value on a recurring basis as of October 3, 2021 (in thousands):

	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Unobservable Inputs (Level 3)
Assets:
Money market instruments	$	3,616	$	—	$	—
Corporate bonds	—		555,992		—
Treasury bills	—		114,998		—
Asset-backed securities	—		83,896		—
Agency bonds	—		18,966		—
Municipal bonds	—		6,966		—
Sovereign bonds	—		1,089		—
Economic hedge forward contracts	—		129		—
Liabilities:
Economic hedge forward contracts	—		88		—

The Company’s money market instruments are reported at fair value based upon the daily market price for identical assets in active markets, and are therefore classified as Level 1.

The Company’s debt securities and forward contracts are reported at fair value based on model-driven valuations in which all significant inputs are observable or can be derived from or corroborated by observable market data for substantially the full term of the asset or liability, and are therefore classified as Level 2. Management is responsible for estimating the fair value of these financial assets and liabilities, and in doing so, considers valuations provided by a large, third-party pricing service. For debt securities, this service maintains regular contact with market makers, brokers, dealers, and analysts to gather information on market movement, direction, trends, and other specific data. They use this information to structure yield curves for various types of debt securities and arrive at the daily valuations. The Company's forward contracts are typically traded or executed in over-the-counter markets with a high degree of pricing transparency. The market participants are generally large commercial banks.

The Company's contingent consideration liabilities are reported at fair value based upon probability-adjusted present values of the consideration expected to be paid using significant inputs that are not observable in the market, and are therefore classified as Level 3. Key assumptions used in these estimates include probability assessments with respect to the likelihood of achieving certain revenue milestones. The fair values of these contingent consideration liabilities were calculated using discount rates consistent with the level of risk of achievement, and are remeasured each reporting period.

The fair value of the contingent consideration liability related to the Company's acquisition of GVi Ventures, Inc. in 2017 was written down to zero in 2019 resulting from a lower level of revenue in the Americas' automotive industry, and the balance remains at zero as of October 3, 2021. The undiscounted potential outcomes related to future contingent consideration range from $0 to $2,500,000 based upon certain revenue levels through April of 2022.

Non-financial Assets that are Measured at Fair Value on a Non-recurring Basis

Non-financial assets, such as property, plant and equipment, operating lease assets, goodwill, and intangible assets, are required to be measured at fair value only when an impairment loss is recognized. The Company evaluates these long-lived assets for impairment whenever events or changes in circumstances, referred to as "triggering events," indicate the carrying value may not be recoverable. The adverse impact of the COVID-19 pandemic on our business in 2020 triggered a review of long-lived assets for potential impairment as of May 26, 2020, which resulted in operating lease asset impairment charges of $2,534,000 (refer to Notes 6 and 16) that were

10

COGNEX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

included in "Restructuring charges" on the Consolidated Statements of Operations, and intangible asset impairment charges of $19,571,000 (refer to Note 8) in the second quarter of 2020. These fair value measurements were based upon the present values of future cash flows using significant inputs that were not observable in the market, and were therefore classified as Level 3.

No triggering event occurred in the nine-month period ended October 3, 2021 that would indicate a potential impairment of long-lived assets. However, the Company continues to monitor global economic conditions, as events or changes in circumstances could result in an impairment of long-lived assets in a future period.

NOTE 4: Cash, Cash Equivalents, and Investments

Cash, cash equivalents, and investments consisted of the following (in thousands):

	October 3, 2021		December 31, 2020
Cash	$	199,863	$	266,609
Money market instruments	3,616		2,464
Cash and cash equivalents	203,479		269,073
Treasury bills	87,014		35,403
Corporate bonds	69,844		32,714
Asset-backed securities	23,133		25,160
Municipal bonds	6,320		1,303
Agency bonds	2,802		—
Sovereign bonds	—		8,660
Current investments	189,113		103,240
Corporate bonds	486,148		203,428
Asset-backed securities	60,763		67,058
Treasury bills	27,984		96,458
Agency bonds	16,164		19,006
Sovereign bonds	1,089		3,440
Municipal bonds	646		5,735
Non-current investments	592,794		395,125
	$	985,386	$	767,438

Cash equivalents are highly liquid investments with insignificant interest rate risk and maturities of ninety days or less at the time of acquisition. Cash equivalents consist primarily of government and institutional money market funds; treasury bills consist of debt securities issued by the U.S. government; corporate bonds consist of debt securities issued by both domestic and foreign companies; asset-backed securities consist of debt securities collateralized by pools of receivables or loans with credit enhancement; municipal bonds consist of debt securities issued by state and local government entities; agency bonds consist of domestic or foreign obligations of government agencies and government-sponsored enterprises that have government backing; and sovereign bonds consist of direct debt issued by foreign governments. All of the Company's securities as of October 3, 2021 and December 31, 2020 were denominated in U.S. Dollars.

Accrued interest receivable is recorded in "Prepaid expenses and other current assets" on the Consolidated Balance Sheet and amounted to $3,481,000 and $1,560,000 as of October 3, 2021 and December 31, 2020, respectively.

11

COGNEX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

The following table summarizes the Company’s available-for-sale investments as of October 3, 2021 (in thousands):

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Current:
Treasury bills	$	86,657	$	357	$	—	$	87,014
Corporate bonds	69,562		290		(8)		69,844
Asset-backed securities	22,990		147		(4)		23,133
Municipal bonds	6,340		3		(23)		6,320
Agency bonds	2,800		2		—		2,802
Non-current:
Corporate bonds	485,290		1,631		(773)		486,148
Asset-backed securities	60,418		346		(1)		60,763
Treasury bills	27,821		163		—		27,984
Agency bonds	16,124		40		—		16,164
Sovereign bonds	1,090		—		(1)		1,089
Municipal bonds	635		11		—		646
	$	779,727	$	2,990	$	(810)	$	781,907

The following table summarizes the Company’s gross unrealized losses and fair values for available-for-sale investments in an unrealized loss position as of October 3, 2021 (in thousands):

	Unrealized Loss Position For:
	Less than 12 Months				12 Months or Greater				Total
	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Corporate bonds	$	216,480	$	(781)	$	—	$	—	$	216,480	$	(781)
Municipal bonds	3,917		(23)		—		—		3,917		(23)
Asset-backed securities	3,732		(5)		—		—		3,732		(5)
Sovereign bonds	1,089		(1)		—		—		1,089		(1)
	$	225,218	$	(810)	$	—	$	—	$	225,218	$	(810)

The Company's allowance for credit losses on debt securities was zero as of October 3, 2021 and December 31, 2020. There was no activity recorded in the allowance for credit losses during the three-month and nine-month periods ended October 3, 2021. The Company recorded no gross credit losses or gross credit recoveries for the three-month period ended September 27, 2020, and gross credit losses of $160,000 and gross credit recoveries of $85,000 for the nine-month period ended September 27, 2020.

The Company recorded gross realized gains on the sale of debt securities totaling $19,000 and $87,000 for the three-month and nine-month periods ended October 3, 2021, respectively, and no gross realized losses on the sale of debt securities for the three-month and nine-month periods ended October 3, 2021. The Company recorded gross realized gains on the sale of debt securities totaling $787,000 and $3,613,000 for the three-month and nine-month periods ended September 27, 2020, respectively, and gross realized losses on the sale of debt securities totaling $1,000 and $22,000, respectively, for the three-month and nine-month periods ended September 27, 2020. These gains and losses are included in "Investment income" on the Consolidated Statements of Operations. Prior to the sale of these securities, unrealized gains and losses for these debt securities, net of tax, are recorded in shareholders’ equity as accumulated other comprehensive loss.

12

COGNEX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

The following table presents the effective maturity dates of the Company’s available-for-sale investments as of October 3, 2021 (in thousands):

	<1 year		1-2 Years		2-3 Years		3-4 Years		4-5 Years		Total
Corporate bonds	$	69,844	$	192,354	$	151,615	$	94,993	$	47,186	$	555,992
Treasury bills	87,014		27,984		—		—		—		114,998
Asset-backed securities	23,133		41,115		6,217		13,431		—		83,896
Agency bonds	2,802		16,164		—		—		—		18,966
Municipal bonds	6,320		646		—		—		—		6,966
Sovereign bonds	—		—		—		—		1,089		1,089
	$	189,113	$	278,263	$	157,832	$	108,424	$	48,275	$	781,907

NOTE 5: Inventories

Inventories consisted of the following (in thousands):

	October 3, 2021		December 31, 2020
Raw materials	$	32,598	$	26,800
Work-in-process	2,975		4,780
Finished goods	45,597		29,250
	$	81,170	$	60,830

The Company recorded provisions for excess and obsolete inventories of $304,000 and $2,120,000 for the three-month and nine-month periods ended October 3, 2021, respectively, and $603,000 and $9,386,000 for the three-month and nine-month periods ended September 27, 2020, respectively, which reduced the carrying value of the inventories to their net realizable value. Estimates in 2020 took into account the global economic conditions resulting from the COVID-19 pandemic.

NOTE 6: Leases

The Company's leases are primarily leased properties across different worldwide locations where the Company conducts its operations. All of these leases are classified as operating leases. Certain leases may contain options to extend or terminate the lease at the Company's sole discretion. There were no options to extend or terminate that were included in the determination of the lease term for the leases outstanding as of October 3, 2021. Certain leases contain leasehold improvement incentives, retirement obligations, escalating clauses, rent holidays, and variable payments tied to a consumer price index. There were no restrictions or covenants for outstanding leases as of October 3, 2021.

The total operating lease expense for the three-month and nine-month periods ended October 3, 2021 was $2,068,000 and $6,091,000, respectively. The total operating lease cash payments for the three-month and nine-month periods ended October 3, 2021 were $2,079,000 and $6,154,000, respectively. The total lease expense for leases with a term of twelve months or less for which the Company elected not to recognize a lease asset or lease liability for the three-month and nine-month periods ended October 3, 2021 was $36,000 and $114,000, respectively.

The total operating lease expense for the three-month and nine-month periods ended September 27, 2020 was $2,047,000 and $6,100,000, respectively. The total operating lease cash payments for the three-month and nine-month periods ended September 27, 2020 were $2,041,000 and $5,995,000, respectively. The total lease expense for leases with a term of twelve months or less for which the Company elected not to recognize a lease asset or lease liability for the three-month and nine-month periods ended September 27, 2020 was $22,000 and $84,000, respectively.

13

COGNEX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Future operating lease cash payments are as follows (in thousands):

Year Ended December 31,	Amount
Remainder of fiscal 2021	$	2,348
2022	8,221
2023	6,588
2024	3,526
2025	2,033
2026	1,297
Thereafter	5,160
	$	29,173

The discounted present value of the future lease cash payments resulted in a lease liability of $26,811,000 and $26,230,000 as of October 3, 2021 and December 31, 2020, respectively. The Company did not have any leases that had not yet commenced but that created significant rights and obligations as of October 3, 2021 or December 31, 2020.

The weighted-average discount rate was 3.5% and 4.0% for the leases outstanding as of October 3, 2021 and December 31, 2020, respectively. The weighted-average remaining lease term was 5.2 and 5.1 years for the leases outstanding as of October 3, 2021 and December 31, 2020, respectively.

Management closed eleven leased offices in 2020, prior to the end of their lease terms, as a part of the Company's restructuring plan (refer to Note 16). The carrying value of the lease assets associated with the majority of these offices was reduced to zero, resulting in operating lease asset impairment charges of $2,534,000 in the second quarter of 2020 that are included in "Restructuring charges" on the Consolidated Statements of Operations. Management is currently negotiating early contract terminations for the remaining lease liability obligations associated with these abandoned offices, which obligations totaled $2,019,000 and $2,877,000 as of October 3, 2021 and December 31, 2020, respectively, and are included in "Operating lease liabilities" on the Consolidated Balance Sheets.

NOTE 7: Goodwill

The changes in the carrying value of goodwill were as follows (in thousands):

Balance as of December 31, 2020	$	244,078
Foreign exchange rate changes	(2,279)
Balance as of October 3, 2021	$	241,799

The adverse impact of the COVID-19 pandemic on our business in 2020 triggered a review of long-lived assets, including goodwill, for potential impairment during the second quarter of 2020. Based on this assessment, management concluded that events and circumstances did not indicate the fair value of the reporting unit was less than its carrying value. Factors that management considered in this qualitative assessment included macroeconomic conditions, industry and market considerations, overall financial performance (both current and projected), changes in management or strategy, changes in the composition or carrying amount of net assets, and market capitalization.

14

COGNEX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 8: Intangible Assets

Amortized intangible assets consisted of the following (in thousands):

	Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Distribution networks	$	38,060	$	38,060	$	—
Completed technologies	24,217		14,548		9,669
Customer relationships	10,578		7,700		2,878
Non-compete agreements	710		478		232
Trademarks	110		107		3
Balance as of October 3, 2021	$	73,675	$	60,893	$	12,782
	Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Distribution networks	$	38,060	$	38,060	$	—
Completed technologies	24,217		12,397		11,820
Customer relationships	10,578		7,160		3,418
Non-compete agreements	710		436		274
Trademarks	110		67		43
Balance as of December 31, 2020	$	73,675	$	58,120	$	15,555

As of October 3, 2021, estimated future amortization expense related to intangible assets was as follows (in thousands):

Year Ended December 31,	Amount
Remainder of fiscal 2021	$	883
2022	3,286
2023	2,594
2024	2,080
2025	1,757
2026	1,452
Thereafter	730
	$	12,782

The adverse impact of the COVID-19 pandemic on our business in 2020 triggered a review of long-lived assets, including intangible assets, for potential impairment during the second quarter of 2020. Based on this assessment, management concluded that certain of the Company's finite-lived intangible assets failed the recoverability test, and recorded impairment charges for these assets equal to the amount by which their carrying value exceeded their fair value. The Company also measured the fair value and recorded an impairment charge for its indefinite-lived intangible asset related to in-process technologies. The fair values were established, with the assistance of an outside valuation advisor, using the income approach based on a discounted cash flow model that estimated future revenue streams and expenses attributable to those revenue streams provided by management.

15

COGNEX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

This review resulted in intangible asset impairment charges totaling $19,571,000 in the second quarter of 2020, primarily related to lower projected cash flows from the technologies and customer relationships acquired from Sualab Co. Ltd. ("Sualab") as a result of the deteriorating global economic conditions from the COVID-19 pandemic. Completed technologies, in-process technologies, and customer relationships acquired from Sualab were impaired in the amounts of $10,070,000, $5,900,000, and $3,382,000, respectively. In addition, customer relationships acquired from EnShape GmbH that had a gross carrying value of $447,000 and accumulated amortization of $228,000 on the measurement date were reduced to zero, resulting in an impairment charge of $219,000. The Company did not record impairment charges related to intangible assets during the three-month or nine-month periods ended October 3, 2021.

NOTE 9: Warranty Obligations

The Company records the estimated cost of fulfilling product warranties at the time of sale based upon historical costs to fulfill claims. Obligations may also be recorded subsequent to the time of sale whenever specific events or changes in circumstances impacting product quality become known that would not have been taken into account using historical data. While we engage in extensive product quality programs and processes, including actively monitoring and evaluating the quality of our component suppliers and third-party contract manufacturers, the Company’s warranty obligation is affected by product failure rates, material usage, and service delivery costs incurred in correcting a product failure. An adverse change in any of these factors may result in the need for additional warranty provisions. Warranty obligations are included in “Accrued expenses” on the Consolidated Balance Sheets.

The changes in the warranty obligation were as follows (in thousands):

Balance as of December 31, 2020	$	5,406
Provisions for warranties issued during the period	2,528
Fulfillment of warranty obligations	(2,517)
Balance as of October 3, 2021	$	5,417

NOTE 10: Derivative Instruments

The Company’s foreign currency risk management strategy is principally designed to mitigate the potential financial impact of changes in the value of transactions and balances denominated in foreign currencies resulting from changes in foreign currency exchange rates. The Company enters into economic hedges utilizing foreign currency forward contracts with maturities of up to 95 days to manage the exposure to fluctuations in foreign currency exchange rates arising primarily from foreign-denominated receivables and payables. The gains and losses on these derivatives are intended to be offset by the changes in the fair value of the assets and liabilities being hedged. These economic hedges are not designated as hedging instruments for hedge accounting treatment.

16

COGNEX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

The Company had the following outstanding forward contracts (in thousands):

	October 3, 2021			December 31, 2020
Currency	Notional Value	USD Equivalent		Notional Value	USD Equivalent
Derivatives Not Designated as Hedging Instruments:
Euro	38,500	$	44,687	50,000	$	61,342
Chinese Renminbi	55,069	8,500		—	—
Mexican Peso	120,000	5,823		155,000	7,776
Korean Won	6,770,000	5,714		6,925,000	6,377
Japanese Yen	600,000	5,405		600,000	5,808
British Pound	3,115	4,224		1,675	2,287
Hungarian Forint	1,235,000	3,992		1,330,000	4,494
Taiwanese Dollar	45,405	1,637		38,035	1,362
Singapore Dollar	1,800	1,328		1,465	1,110
Canadian Dollar	1,370	1,080		1,285	1,010

Information regarding the fair value of the outstanding forward contracts was as follows (in thousands):

	Asset Derivatives					Liability Derivatives
	Balance	Fair Value				Balance	Fair Value
	Sheet Location	October 3, 2021		December 31, 2020		Sheet Location	October 3, 2021		December 31, 2020
Derivatives Not Designated as Hedging Instruments:
Economic hedge forward contracts	Prepaid expenses and other current assets	$	129	$	265	Accrued expenses	$	88	$	38

The following table presents the gross activity for all derivative assets and liabilities which were presented on a net basis on the Consolidated Balance Sheets due to the right of offset with each counterparty (in thousands):

Asset Derivatives					Liability Derivatives
	October 3, 2021		December 31, 2020			October 3, 2021		December 31, 2020
Gross amounts of recognized assets	$	129	$	265	Gross amounts of recognized liabilities	$	88	$	38
Gross amounts offset	—		—		Gross amounts offset	—		—
Net amount of assets presented	$	129	$	265	Net amount of liabilities presented	$	88	$	38

Information regarding the effect of derivative instruments on the consolidated financial statements was as follows (in thousands):

	Location in Financial Statements	Three-months Ended				Nine-months Ended
		October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
Derivatives Not Designated as Hedging Instruments:
Gains (losses) recognized in current operations	Foreign currency gain (loss)	$	1,529	$	(1,521)	$	3,676	$	(9,701)

17

COGNEX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 11: Revenue Recognition

The following table summarizes disaggregated revenue information by geographic area based upon the customer's country of domicile (in thousands):

	Three-months Ended				Nine-months Ended
	October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
Americas	$	113,758	$	86,482	$	330,012	$	215,696
Europe	65,146		60,189		182,161		144,758
Greater China	65,813		77,292		163,757		135,593
Other Asia	40,131		27,110		117,103		91,358
	$	284,848	$	251,073	$	793,033	$	587,405

The following table summarizes disaggregated revenue information by revenue type (in thousands):

	Three-months Ended				Nine-months Ended
	October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
Standard products and services	$	212,567	$	174,797	$	669,215	$	486,458
Application-specific customer solutions	72,281		76,276		123,818		100,947
	$	284,848	$	251,073	$	793,033	$	587,405

Costs to Fulfill a Contract

Costs to fulfill a contract are included in "Prepaid expenses and other current assets" on the Consolidated Balance Sheet and amounted to $13,308,000 and $6,846,000 as of October 3, 2021 and December 31, 2020, respectively.

Accounts Receivable, Contract Assets, and Contract Liabilities

Accounts receivable represent amounts billed and currently due from customers which are reported at their net estimated realizable value. The Company maintains an allowance against its accounts receivable for credit losses. Contract assets consist of unbilled revenue which arises when revenue is recognized in advance of billing for certain application-specific customer solutions contracts. Contract liabilities consist of deferred revenue and customer deposits which arise when amounts are billed to or collected from customers in advance of revenue recognition.

The following table summarizes the allowance for credit losses activity for the nine-month period ended October 3, 2021 (in thousands):

Balance as of December 31, 2020	$	831
Increases to the allowance for credit losses	—
Write-offs, net of recoveries	(39)
Foreign exchange rate changes	—
Balance as of October 3, 2021	$	792

18

COGNEX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

The following table summarizes the deferred revenue and customer deposits activity for the nine-month period ended October 3, 2021 (in thousands):

Balance as of December 31, 2020	$	21,274
Deferral of revenue billed in the current period, net of recognition	33,888
Recognition of revenue deferred in prior period	(17,130)
Foreign exchange rate changes	(189)
Balance as of October 3, 2021	$	37,843

As a practical expedient, the Company has elected not to disclose the aggregate amount of the transaction price allocated to unsatisfied performance obligations, as our contracts have an original expected duration of less than one year.

NOTE 12: Stock-Based Compensation Expense

Stock Plans

The Company’s stock-based awards that result in compensation expense consist of stock options and restricted stock units ("RSUs"). As of October 3, 2021, the Company had 15,661,000 shares available for grant under its stock plans. Stock options are granted with an exercise price equal to the market value of the Company’s common stock at the grant date and generally vest over four or five years based upon continuous service and expire ten years from the grant date. RSUs generally vest upon three years of continuous employment or incrementally over such three-year period. Participants are not entitled to dividends on RSUs.

Stock Options

The following table summarizes the Company’s stock option activity for the nine-month period ended October 3, 2021:

	Shares (in thousands)	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of December 31, 2020	8,970	$	44.73
Granted	549	88.80
Exercised	(1,582)	37.70
Forfeited or expired	(225)	50.29
Outstanding as of October 3, 2021	7,712	$	49.15	6.79	$	252,476
Exercisable as of October 3, 2021	3,290	$	39.03	5.56	$	139,215
Options vested or expected to vest as of October 3, 2021 (1)	7,157	$	48.36	6.70	$	239,568

 (1) In addition to the vested options, the Company expects a portion of the unvested options to vest at some point in the future. Options expected to vest are calculated by applying an estimated forfeiture rate to the unvested options.

19

COGNEX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

The fair values of stock options granted in each period presented were estimated using the following weighted-average assumptions:

	Three-months Ended				Nine-months Ended
	October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
Risk-free rate	1.4	%	—	%	1.3	%	1.6	%
Expected dividend yield	0.28	%	—	%	0.27	%	0.43	%
Expected volatility	39	%	—	%	39	%	37	%
Expected term (in years)	7.1		—		6.0		6.0

No stock options were granted during the three-month period ended September 27, 2020.

Risk-free rate

The risk-free rate was based upon a treasury instrument whose term was consistent with the contractual term of the option.

Expected dividend yield

Generally, the current dividend yield is calculated by annualizing the cash dividend declared by the Company’s Board of Directors and dividing that result by the closing stock price on the grant date. 

Expected volatility

The expected volatility was based upon a combination of historical volatility of the Company’s common stock over the contractual term of the option and implied volatility for traded options of the Company’s stock.

Expected term

The expected term was derived from the binomial lattice model from the impact of events that trigger exercises over time.

The weighted-average grant-date fair values of stock options granted during the three-month and nine-month periods ended October 3, 2021 were $35.64 and $33.78, respectively, and during the nine-month period ended September 27, 2020 was $18.52. There were no stock options granted during the three-month period ended September 27, 2020.

The total intrinsic values of stock options exercised for the three-month and nine-month periods ended October 3, 2021 were $21,415,000 and $75,363,000, respectively, and for the three-month and nine-month periods ended September 27, 2020 were $62,787,000 and $116,600,000, respectively. The total fair values of stock options vested for the three-month and nine-month periods ended October 3, 2021 were $1,498,000 and $38,928,000, respectively, and for the three-month and nine-month periods ended September 27, 2020 were $1,331,000 and $39,282,000, respectively.

Restricted Stock Units (RSUs)

The following table summarizes the Company's RSUs activity for the nine-month period ended October 3, 2021:

	Shares (in thousands)	Weighted-Average Grant Date Fair Value
Nonvested as of December 31, 2020	554	$	51.27
Granted	318	87.38
Vested	(15)	56.61
Forfeited or expired	(43)	56.49
Nonvested as of October 3, 2021	814	$	65.01

20

COGNEX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

The weighted-average grant-date fair values of RSUs granted during the three-month and nine-month periods ended October 3, 2021 were $86.34 and $87.38, respectively, and during the three-month and nine-month periods ended September 27, 2020 were $67.14 and $51.73, respectively. There were 15,000 RSUs that vested during the nine-month period ended October 3, 2021. There were no RSUs that vested during the three-month period ended October 3, 2021 or the three-month and nine-month periods ended September 27, 2020.

Stock-Based Compensation Expense

The Company segments its employee population into two groups: one consisting of senior management and another consisting of all other employees. The Company currently applies an estimated annual forfeiture rate of 8% to all stock-based awards for senior management and a rate of 12% for all other employees. Each year during the first quarter, the Company revises its forfeiture rate based on updated estimates of employee turnover. This resulted in a decrease to compensation expense of $255,000 in 2021 and an increase to compensation expense of $1,787,000 in 2020.

As of October 3, 2021, total unrecognized compensation expense related to non-vested equity awards, including stock options and RSUs, was $56,579,000, which is expected to be recognized over a weighted-average period of 1.6 years.

The total stock-based compensation expense and the related income tax benefit recognized for the three-month period ended October 3, 2021 were $10,614,000 and $1,637,000, respectively, and for the nine-month period ended October 3, 2021 were $33,353,000 and $5,101,000, respectively. The total stock-based compensation expense and the related income tax benefit recognized for the three-month period ended September 27, 2020 were $9,268,000 and $1,524,000, respectively, and for the nine-month period ended September 27, 2020 were $32,076,000 and $5,365,000, respectively. Stock-based compensation expense recognized for the three-month and nine-month periods ended September 27, 2020 included credits of $1,401,000 relating to grants cancelled as a result of the Company's workforce reduction in the second quarter of 2020. No compensation expense was capitalized as of October 3, 2021 or December 31, 2020.

The following table presents the stock-based compensation expense by caption for each period presented on the Consolidated Statements of Operations (in thousands):

	Three-months Ended				Nine-months Ended
	October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
Cost of revenue	$	366	$	324	$	965	$	1,041
Research, development, and engineering	3,091		2,815		10,158		10,582
Selling, general, and administrative	7,157		6,129		22,230		20,453
	$	10,614	$	9,268	$	33,353	$	32,076

NOTE 13: Stock Repurchase Program

In October 2018, the Company's Board of Directors authorized the repurchase of $200,000,000 of the Company's common stock. As of October 3, 2021, the Company repurchased 3,398,000 shares at a cost of $169,643,000 under this program, including 581,000 shares at a cost of $48,294,000 during the nine-month period ended October 3, 2021, leaving a remaining balance of $30,357,000. 1,215,000 shares at a cost of $51,036,000 were repurchased during the nine-month period ended September 27, 2020 under this October 2018 program. On March 12, 2020, the Company's Board of Directors authorized the repurchase of an additional $200,000,000 of the Company's common stock. Purchases under this March 2020 program will commence upon completion of the October 2018 program. The Company may repurchase shares under this program in future periods depending on a variety of factors, including, among other things, the impact of dilution from employee stock awards, stock price, share availability, and cash requirements. The Company is authorized to make repurchases of its common stock through open market purchases, pursuant to Rule 10b5-1 trading plans, or in privately negotiated transactions.

21

COGNEX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 14: Income Taxes

A reconciliation of the United States federal statutory corporate tax rate to the Company’s income tax expense, or effective tax rate, was as follows:

	Three-months Ended				Nine-months Ended
	October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
Income tax expense at U.S. federal statutory corporate tax rate	21	%	21	%	21	%	21	%
State income taxes, net of federal benefit	2	%	1	%	2	%	1	%
Foreign tax rate differential	(5)	%	(5)	%	(5)	%	(5)	%
Tax credit	(1)	%	(1)	%	(1)	%	(1)	%
Discrete tax benefit related to stock options	(4)	%	(4)	%	(4)	%	(9)	%
Discrete tax expense (benefit) related to tax return filings	(3)	%	—	%	(1)	%	3	%
Other	1	%	2	%	1	%	2	%
Income tax expense	11	%	14	%	13	%	12	%

The Company recorded discrete tax benefits arising from the difference between the deduction for tax purposes and the compensation cost recognized for financial reporting purposes from stock option exercises that resulted in a favorable impact to the effective tax rate of 4% for both the three-month and nine-month periods ended October 3, 2021, and 4% and 9% for the three-month and nine-month periods ended September 27, 2020, respectively. In addition to stock option exercises, other discrete adjustments recorded included the final true-up of the prior year's tax accrual upon filing the related tax return that resulted in a favorable impact to the effective tax rate of 3% and 1% for the three-month and nine-month periods ended October 3, 2021, respectively, and an unfavorable impact to the effective tax rate of 3% for the nine-month period ended September 27, 2020.

Excluding the impact of these discrete items, the Company’s effective tax rate was 18% of pre-tax income for the three-month and nine-month periods ended October 3, 2021, and 18% of pre-tax income for the same periods in 2020.

During the nine-month period ended October 3, 2021, the Company recorded a $495,000 increase in reserves for income taxes, net of deferred tax benefit. Estimated interest and penalties included in these amounts totaled $450,000 for the nine-month period ended October 3, 2021.

The Company’s reserve for income taxes, including gross interest and penalties, was $15,833,000 as of October 3, 2021, which included $14,805,000 classified as a non-current liability and $1,028,000 recorded as a reduction to non-current deferred tax assets. If the Company’s tax positions were sustained or the statutes of limitations related to certain positions expired, these reserves would be released and income tax expense would be reduced in a future period. During the three-month period ending October 3, 2021, the Company released $648,000 in reserves related to statute expiration and tax return positions.

The Company has defined its major tax jurisdictions as the United States, Ireland, China, and Korea, and within the United States, Massachusetts. The statutory tax rate is 12.5% in Ireland, 25% in China, and 25% in Korea compared to the U.S. federal statutory corporate tax rate of 21%. These differences resulted in a favorable impact to the effective tax rate of 5% for both the three-month and nine-month periods ended October 3, 2021, and for the same periods in 2020.

Within the United States, the tax years 2017 through 2020 remain open to examination by the Internal Revenue Service ("IRS") and various state tax authorities. The tax years 2016 through 2020 remain open to examination by various taxing authorities in other jurisdictions in which the Company operates. The Company is under audit by the IRS for the tax years 2017 and 2018. Additionally, the Company is under audit by the Commonwealth of Massachusetts for tax years 2017 and 2018. Management believes the Company is adequately reserved for these audits. The final determination of tax audits could result in favorable or unfavorable changes in our estimates.

22

COGNEX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 15: Weighted-Average Shares

Weighted-average shares were calculated as follows (in thousands):

	Three-months Ended		Nine-months Ended
	October 3, 2021	September 27, 2020	October 3, 2021	September 27, 2020
Basic weighted-average common shares outstanding	176,812	173,943	176,572	172,881
Effect of dilutive equity awards	3,530	3,195	3,537	3,157
Weighted-average common and common-equivalent shares outstanding	180,342	177,138	180,109	176,038

Stock options to purchase 586,000 and 655,000 shares of common stock, on a weighted-average basis, were outstanding during the three-month and nine-month periods ended October 3, 2021, respectively, and 1,416,000 and 5,540,000 for the same periods in 2020, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 1,000 shares of common stock, on a weighted-average basis, were outstanding during both the three-month and nine-month periods ended October 3, 2021, respectively, and 3,000 and 2,000 for the same periods in 2020, but were not included in the calculation of dilutive net income per share because they were anti-dilutive.

NOTE 16: Restructuring Charges

On May 26, 2020, the Company's Board of Directors approved a restructuring plan intended to reduce the Company's operating costs, optimize its business model, and address the impact of the COVID-19 pandemic. The restructuring plan included a global workforce reduction of approximately 8% and office closures.

As of December 31, 2020, the majority of these actions were completed and no additional charges are expected to be incurred in future periods in relation to this restructuring plan. There were no restructuring charges recognized during the three-month or nine-month periods ended October 3, 2021.

The following table summarizes the restructuring charges incurred in the three-month and nine-month periods ended September 27, 2020 (in thousands):

	Incurred in the Three-months Ended September 27, 2020		Incurred in the Nine-months Ended September 27, 2020
One-time termination benefits	$	(36)	$	10,350
Contract termination costs	104		4,099
Other associated costs	183		600
	$	251	$	15,049

One-time termination benefits included severance, health insurance, and outplacement services for 181 employees who were either terminated during the second quarter of 2020, or were notified during the second quarter of 2020 that they would be terminated at a future date. For employees not required to render service beyond a minimum retention period, the one-time termination benefits were recognized in the second quarter of 2020. Otherwise, these benefits, including retention bonuses for selected employees, were recognized over the service period, which was completed by December 31, 2020.

Contract termination costs included operating lease asset impairment charges for offices closed prior to the end of the contractual lease term. These costs also included the write-off of leasehold improvements and other equipment related to these abandoned offices that had no alternative use, as well as other associated operating costs, such as utilities, that the Company is obligated to pay for the remainder of the lease term. These contract termination costs were primarily recognized in the second quarter of 2020 when the Company ceased using the property for economic benefit.

23

COGNEX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Other associated costs primarily included legal fees related to the employee termination actions, which were recognized when the services were performed.

The following table summarizes the activity for the nine-month period ended October 3, 2021 in the Company’s restructuring reserve which is included in “Accrued expenses” on the Consolidated Balance Sheets (in thousands):

	One-time Termination Benefits		Contract Termination Costs		Other Associated Costs		Total
Balance as of December 31, 2020	$	1,624	$	750	$	15	$	2,389
Cash payments	(1,133)		(176)		(15)		(1,324)
Foreign exchange rate changes	—		(5)		—		(5)
Balance as of October 3, 2021	$	491	$	569	$	—	$	1,060

NOTE 17: Subsequent Events

On November 4, 2021, the Company’s Board of Directors declared a cash dividend of $0.065 per share. The dividend is payable on December 3, 2021 to all shareholders of record as of the close of business on November 19, 2021.

24

ITEM 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

Certain statements made in this report, as well as oral statements made by the Company from time to time, constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Readers can identify these forward-looking statements by our use of the words “expects,” “anticipates,” “estimates,” “believes,” “projects,” “intends,” “plans,” “will,” “may,” “shall,” “could,” “should,” and similar words and other statements of a similar sense. These statements are based on our current estimates and expectations as to prospective events and circumstances, which may or may not be in our control and as to which there can be no firm assurances given. These forward-looking statements, which include statements regarding business and market trends, future financial performance, the expected impact of the COVID-19 pandemic on our assets, business and results of operations, customer demand and order rates and timing of related revenue, managing supply shortages, future product mix, restructuring and other cost-savings initiatives, research and development activities, sales and marketing activities, new product offerings, capital expenditures, investments, liquidity, dividends and stock repurchases, strategic and growth plans, and estimated tax benefits and expenses and other tax matters, involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include: (1) the impact, duration, and severity of the COVID-19 pandemic; (2) potential disruptions to our business due to restructuring activities; (3) the loss of, or curtailment of purchases by, large customers in the consumer electronics and logistics industries; (4) the reliance on revenue from the automotive industry; (5) the reliance on key suppliers to manufacture and deliver critical components for our products; (6) disruptions in the supply chain, which could impact timely delivery of customer orders, cause customer orders to decrease, or increase costs to fulfill orders, including costs for components or freight; (7) the failure to effectively manage product transitions or accurately forecast customer demand; (8) the inability to design and manufacture high-quality products; (9) the inability to attract and retain skilled employees and maintain our unique corporate culture; (10) the failure to effectively manage our growth; (11) the inability to achieve growth in revenue and profits from the logistics industry; (12) the technological obsolescence of current products and the inability to develop new products; (13) the failure to properly manage the distribution of products and services; (14) the impact of competitive pressures; (15) the challenges in integrating and achieving expected results from acquired businesses; (16) potential disruptions in our business systems; (17) information security breaches and cyber-attacks; (18) the inability to protect our proprietary technology and intellectual property; (19) potential impairment charges with respect to our investments or acquired intangible assets; (20) exposure to additional tax liabilities; (21) fluctuations in foreign currency exchange rates and the use of derivative instruments; (22) our involvement in time-consuming and costly litigation; (23) unfavorable global economic conditions; and (24) economic, political, and other risks associated with international sales and operations. The foregoing list should not be construed as exhaustive and we encourage readers to refer to the detailed discussion of risk factors included in Part I - Item 1A of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as updated by Part II - Item 1A of this Quarterly Report on Form 10-Q. The Company cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. The Company disclaims any obligation to subsequently revise forward-looking statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date such statements are made.

Executive Overview

Cognex Corporation is a leading worldwide provider of machine vision products that capture and analyze visual information in order to automate manufacturing and distribution tasks where vision is required. In addition to product revenue derived from the sale of machine vision products, the Company also generates revenue by providing maintenance and support, consulting, and training services to its customers; however, service revenue accounted for less than 10% of total revenue for all periods presented.

Cognex machine vision is used to automate manufacturing and distribution processes in a variety of industries, where the technology is widely recognized as an important component of automated production and quality assurance. Virtually every manufacturer can achieve better quality and manufacturing efficiency by using machine vision, and therefore, Cognex products are used by a broad base of customers across a variety of industries, including consumer electronics, automotive, consumer products, food and beverage, and medical-related. Cognex products are also used to automate distribution processes in the logistics industry, including for applications in retail distribution and e-commerce to scan, track, and sort goods through distribution centers.

Revenue for the third quarter of 2021 totaled $284,848,000, an increase of 13% from the third quarter of 2020. The

25

increase was due to significantly higher revenue from the logistics industry, which was our largest and fastest-growing market in the third quarter of 2021, partially offset by lower consumer electronics revenue that was primarily driven by the timing of large customer deployments.

Gross margin as a percentage of revenue was 70% for the third quarter of 2021 compared to 76% for the third quarter of 2020, primarily due to an unfavorable revenue mix, as well as higher prices paid to purchase inventories in the third quarter of 2021.

Operating expenses increased by $16,892,000, or 18%, for the third quarter of 2021 compared to the same quarter in 2020, which had relatively low operating expenses due to our restructuring actions in the second quarter of 2020. The increase was due, in part, to higher personnel-related costs, which included the impact of headcount additions to support our future growth plans, as well as higher incentive compensation costs and the impact of foreign currency exchange rate changes.

As a result of the lower gross margin percentage and higher operating expenses, operating income decreased to 31% of revenue for the third quarter of 2021 from 38% of revenue for the third quarter of 2020. Net income was 28% of revenue for the third quarter of 2021, or $0.44 per diluted share, compared to 35% of revenue for the third quarter of 2020, or $0.49 per diluted share.

Results of Operations

As foreign currency exchange rates are a factor in understanding period-to-period comparisons, we believe the presentation of results on a constant-currency basis in addition to reported results helps improve investors’ ability to understand our operating results and evaluate our performance in comparison to prior periods. We also use results on a constant-currency basis as one measure to evaluate our performance. Constant-currency information compares results between periods as if exchange rates had remained constant period-over-period. We generally refer to such amounts calculated on a constant-currency basis as excluding the impact of foreign currency exchange rate changes. Results on a constant-currency basis are not in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and should be considered in addition to, and not as a substitute for, results prepared in accordance with U.S. GAAP.

Revenue

Revenue increased by $33,775,000, or 13%, for the three-month period and increased by $205,628,000, or 35%, for the nine-month period. The most significant increase came from customers in the logistics industry, particularly in the e-commerce and omni-channel retail sectors. Growth in the automotive, semiconductor, medical-related, and consumer products industries also contributed to the increase. The increases in these industries were partially offset by a decrease in revenue from the consumer electronics industry. A higher concentration of consumer electronics revenue from large customer deployments in the third quarter of 2020 resulted in a more significant decrease in revenue in this industry for the three-month period in 2021.

We believe the increases in revenue for the three-month and nine-month periods would have been moderately higher were it not for global supply shortages that continued to delay customer deliveries of certain products and worsened throughout the quarter. Based in part on product availability, the Company was able to fulfill customer orders in the logistics industry in the third quarter of 2021 that were originally expected to be fulfilled in the fourth quarter of 2021, which lessened the impact of delays of other customer deliveries during the third quarter.

From a geographic perspective, revenue from customers based in the Americas increased by 32% for the three-month period and 53% for the nine-month period driven primarily by higher revenue in the logistics industry. Revenue from customers in medical-related industries was also notably higher for nine-month period.

Revenue from customers based in Europe increased by 8% for the three-month period and 26% for the nine-month period. Changes in foreign currency exchange rates resulted in a higher level of reported revenue in 2021, as sales denominated in Euros were translated into U.S. Dollars at a higher rate. Excluding the impact of foreign currency exchange rate changes, revenue from customers based in Europe increased by 7% for the three-month period and 20% for the nine-month period. The increase came from customers in a variety of industries, most notably logistics, automotive, and consumer products, partially offset by lower revenue in the consumer electronics industry. The decline in revenue from consumer electronics was partially a result of procurement changes made by certain customers, shifting their purchases to China from Europe.

Revenue from customers based in Greater China decreased by 15% for the three-month period and increased by 21% for the nine-month period. Changes in foreign currency exchange rates resulted in a higher level of reported revenue in 2021, as sales denominated in Chinese Renminbi were translated into U.S. Dollars at a higher rate. Excluding the impact of foreign currency exchange rate changes, revenue from customers based in Greater China

26

decreased by 22% for the three-month period and increased by 13% for the nine-month period. Although revenue increased in a variety of industries over the prior year, most notably automotive and semiconductor, this increase was offset by a decrease in consumer electronics revenue for the three-month period, as there was a higher concentration of this revenue from large customer deployments in the third quarter of 2020 as compared to the third quarter of 2021.

Revenue from other countries in Asia increased by 48% for the three-month period and 28% for the nine-month period due to higher revenue in a range of industries, including automotive and semiconductor.

As of the date of this report, we expect revenue for the fourth quarter of 2021 to be lower than the third quarter of 2021 and relatively flat with the fourth quarter of 2020. The decrease from the third quarter of 2021 is expected to result from lower revenue in the consumer electronics and logistics industries, due particularly to the timing of large customer deployments in these industries, as well as the earlier fulfillment of customer orders in the logistics industry in the third quarter of 2021. Revenue in the fourth quarter of 2020 benefited from higher consumer demand for electronic products that we believe related to the COVID-19 pandemic. Our current expectations regarding revenue for the fourth quarter of 2021 assume continued delays of customer deliveries for certain products due to global supply shortages that we believe will continue throughout the quarter, while similar challenges did not exist in the prior year.

Gross Margin

Gross margin as a percentage of revenue was 70% and 74% for the three-month and nine-month periods in 2021, respectively, compared to 76% and 74% for the same periods in 2020. The decrease for the three-month period was primarily due to an unfavorable revenue mix. This decrease was a result of delays of higher-margin product sales due to global supply shortages, as well as a greater percentage of total revenue coming from the logistics industry, which has relatively lower gross margins. Logistics revenue for the third quarter of 2021 included some comparatively lower margins from strategic logistics projects. The decrease for the three-month period was also due to higher prices paid to purchase inventories in 2021 due primarily to global supply chain constraints, including higher costs for components and freight, that we expect to continue for several quarters.

For the nine-month period, the unfavorable impact of a higher percentage of logistics revenue and higher inventory purchases prices was offset by lower provisions for excess and obsolete inventories as compared to the prior year and manufacturing efficiencies related to the higher revenue level. The higher provisions for excess and obsolete inventories in 2020 took into account the global economic conditions resulting from the COVID-19 pandemic.

As of the date of this report, we expect gross margin as a percentage of revenue for the fourth quarter of 2021 to be in the low-70% range. We expect to have a more favorable revenue mix in the fourth quarter of 2021 as compared to the third quarter of 2021. We also expect higher inventory purchase prices in the fourth quarter of 2021 as compared to the third quarter of 2021.

Operating Expenses

Research, Development, and Engineering Expenses

Research, development, and engineering (RD&E) expenses increased by $4,236,000, or 14%, for the three-month period and $3,300,000, or 3%, for the nine-month period as detailed in the table below (in thousands).

	Three-month period		Nine-month period
RD&E expenses in 2020	$	30,240	$	96,583
Foreign currency exchange rate changes	492		3,057
Incentive compensation	377		1,928
Outsourced engineering services	1,171		950
Personnel-related costs	1,506		(1,131)
Other	690		(1,504)
RD&E expenses in 2021	$	34,476	$	99,883

RD&E expenses increased due to foreign currency exchange rate changes, as costs denominated in foreign currencies were translated into U.S. Dollars at a higher rate. Incentive bonus accruals were also higher than the prior year based on management's assessment of the Company's expected performance against relevant full-year goals. Higher spending on outsourced engineering services due to the timing of product development activities,

27

including engineering prototypes for large sales opportunities, also contributed to the increase.

These increases were partially offset by lower personnel-related costs for the nine-month period due to a workforce reduction in the second quarter of 2020. Higher costs from annual salary increases and fringe benefits provided to employees, as well as headcount additions to support new product initiatives, partially offset the lower costs from the workforce reduction in the nine-month period and resulted in an increase in costs for the three-month period.

RD&E expenses as a percentage of revenue were 12% and 13% for the three-month period and nine-month period, respectively, compared to 12% and 16% for the same periods in 2020. We believe that a continued commitment to RD&E activities is essential in order to maintain or achieve product leadership with our existing products and to provide innovative new product offerings, as well as to provide engineering support for large customers. In addition, we consider our ability to accelerate the time to market for new products to be critical to our revenue growth. This quarterly percentage is impacted by revenue levels and investing cycles.

Selling, General, and Administrative Expenses

Selling, general, and administrative (SG&A) expenses increased by $12,907,000, or 20%, for the three-month period and $32,883,000, or 17%, for the nine-month period as detailed in the table below (in thousands).

	Three-month period		Nine-month period
SG&A expenses in 2020	$	64,206	$	193,497
Incentive compensation	2,931		14,292
Foreign currency exchange rate changes	1,207		7,029
Personnel-related costs	4,313		3,292
Business system investments	624		1,931
Stock-based compensation expense	1,037		1,486
Marketing programs	455		1,426
Recruiting costs	524		1,187
Travel expenses	949		754
Other	867		1,486
SG&A expenses in 2021	$	77,113	$	226,380

SG&A expenses increased due to higher expenses related to annual incentive compensation plans, which include incentive bonuses and sales commissions. Incentive bonus accruals were higher than the prior year based on management's assessment of the Company's expected performance against relevant full-year goals. Likewise, sales commissions increased due to the higher business levels. Personnel-related costs increased due to higher costs from annual salary increases and fringe benefits provided to employees, as well as sales headcount additions in strategic growth areas of the business. The increase was more significant in the three-month period than in the nine-month period due to the impact of the workforce reduction that took place in the second quarter of 2020. In addition to salaries and fringe benefits, these personnel-related costs included sales commissions and travel expenses related to the additional headcount. The headcount additions also drove higher recruiting costs.

Foreign currency exchange rate changes resulted in a higher level of SG&A expenses as compared to the prior year, as costs denominated in foreign currencies were translated into U.S. Dollars at a higher rate. Expenses were also higher due to investments the Company is making in business systems related to its sales process, including systems to help our sales team more efficiently manage customer relationships and sales opportunities. A portion of these costs is expensed as incurred, while the majority of these investments will be accounted for as a capital asset that is expected to be placed into service in the first quarter of 2022. In addition, stock-based compensation increased as a result of changes in equity awards over time (e.g., increased number of restricted stock units, varied vesting schedules, timing of awards, etc.), partially offset by decreases due to the impact of forfeiture rates revised in the first quarter of 2021. Stock-based compensation expense for the nine-month period also increased due to credits related to the workforce reduction that were recorded in the second quarter of 2020 and did not repeat. The Company also increased spending on marketing programs in an effort to generate future sales opportunities, particularly related to new product introductions, and incurred higher travel expenses as restrictions related to COVID-19 continued to ease in certain regions.

28

Restructuring and Intangible Asset Impairment Charges

On May 26, 2020, the Company's Board of Directors approved a restructuring plan intended to reduce the Company's operating costs, optimize its business model, and address the impact of the COVID-19 pandemic. The Company recorded restructuring charges of $251,000 and $15,049,000 for the three-month and nine-month periods in 2020, respectively, as a result of actions related to the restructuring plan, which included a global workforce reduction of approximately 8% and office closures. In addition, the adverse impact of the COVID-19 pandemic triggered a review of long-lived assets for potential impairment in the second quarter of 2020. This review resulted in intangible asset impairment charges totaling $19,571,000 recorded in the second quarter of 2020.

Non-operating Income (Expense)

The Company recorded foreign currency losses of $586,000 and $2,233,000 for the three-month and nine-month periods in 2021, respectively, compared to foreign currency gains of $2,357,000 and foreign currency losses of $310,000 for the same periods in 2020. Foreign currency gains and losses result primarily from the revaluation and settlement of accounts receivable, accounts payable, and intercompany balances that are reported in one currency and collected in another.

Investment income decreased by $742,000, or 30%, for the three-month period and $5,985,0000, or 54%, for the nine-month period. The decrease was due primarily to lower yields on the Company's portfolio of debt securities, partially offset by higher invested balances.

The Company recorded other expense of $125,000 and $420,000 for the three-month and nine-month periods in 2021, respectively, compared to other expense of $173,000 and $153,000 for the same periods in 2020. Other income (expense) includes fair value adjustments of contingent consideration liabilities arising from business acquisitions.

Income Tax Expense (Benefit)

The Company’s effective tax rate was 11% and 13% of pre-tax income for the three-month and nine-month periods in 2021, respectively, compared to 14% and 12% for the same periods in 2020.

The effective tax rate included a decrease in tax expense of $3,250,000 and $9,888,000 for the three-month and nine-month periods in 2021, respectively, and $4,354,000 and $10,447,000 for the same periods in 2020, related to stock options, primarily from the excess tax benefit arising from the difference between the deduction for tax purposes and the compensation cost recognized for financial reporting purposes from stock option exercises. The Company cannot accurately predict the level of stock option exercises by employees in future periods.

Other discrete tax items included a decrease in tax expense of $3,012,000 and $2,477,000 for the three-month and nine-month periods in 2021, respectively, and an increase in tax expense of $129,000 and $3,638,000 for the same periods in 2020, respectively, from the final true-up of the prior year's tax accrual upon filing the related tax return.

Excluding the impact of these discrete items, the Company’s effective tax rate was 18% of pre-tax income for the three-month and nine-month periods in both 2021 and 2020.

Liquidity and Capital Resources

The Company has historically been able to generate positive cash flow from operations, which has funded its operating activities and other cash requirements and has resulted in an accumulated cash and investment balance of $985,386,000 as of October 3, 2021. The Company has established guidelines relative to credit ratings, diversification, and maturities of its investments that maintain liquidity.

The Company’s cash requirements for the nine-month period ended October 3, 2021 were primarily met with positive cash flows from operations and the proceeds from stock option exercises. Cash requirements consisted of operating activities, the repurchase of common stock, the payment of dividends, and capital expenditures. Cash flows from operating activities included an increase in inventories to support higher business levels and to secure key strategic components. The Company expects inventory levels to continue to increase for the remainder of the year as we receive inventory that we are purchasing in response to global supply chain challenges.

Capital expenditures for the nine-month period ended October 3, 2021 totaled $10,689,000 and consisted primarily of computer hardware and software, manufacturing test equipment related to new product introductions, and improvements made to the Company's headquarters building in Natick, Massachusetts. In 2021, the Company is making investments in business systems related to its sales process, the majority of which will be accounted for as a capital asset that is expected to be placed into service in the first quarter of 2022.

In October 2018, the Company's Board of Directors authorized the repurchase of $200,000,000 of the Company's

29

common stock. As of October 3, 2021, the Company repurchased 3,398,000 shares at a cost of $169,643,000 under this program, including 581,000 shares at a cost of $48,294,000 during the nine-month period ended October 3, 2021, leaving a remaining balance of $30,357,000. On March 12, 2020, the Company's Board of Directors authorized the repurchase of an additional $200,000,000 of the Company's common stock. Purchases under this March 2020 program will commence upon completion of the October 2018 program. The Company may repurchase shares under this program in future periods depending on a variety of factors, including, among other things, the impact of dilution from employee stock awards, stock price, share availability, and cash requirements. The Company is authorized to make repurchases of its common stock through open market purchases, pursuant to Rule 10b5-1 trading plans, or in privately negotiated transactions.

The Company’s Board of Directors declared and paid cash dividends of $0.060 per share in the first, second, and third quarters of 2021, totaling $31,800,000. Future dividends will be declared at the discretion of the Company's Board of Directors and will depend upon such factors as the Board deems relevant, including, among other things, the Company's ability to generate positive cash flow from operations.

The Company believes that its existing cash and investment balances, together with cash flow from operations, will be sufficient to meet its operating, investing, and financing activities for the next twelve months. In addition, the Company has no long-term debt and does not anticipate needing debt financing in the near future. We believe that our strong cash position has put us in a relatively good position with respect to our longer-term liquidity needs.

New Pronouncements

Refer to Part I - Note 2 within this Form 10-Q, for a full description of recently issued accounting pronouncements including the expected dates of adoption and the expected impact on the financial position and results of operations of the Company.

ITEM 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes to the Company’s exposures to market risk since December 31, 2020.

ITEM 4: CONTROLS AND PROCEDURES

As required by Rules 13a-15 and 15d-15 of the Securities Exchange Act of 1934, the Company has evaluated, with the participation of management, including the Chief Executive Officer and the Chief Financial Officer, the effectiveness of its disclosure controls and procedures (as defined in such rules) as of the end of the period covered by this report. Based on such evaluation, the Chief Executive Officer and Chief Financial Officer concluded that such disclosure controls and procedures were effective as of that date. From time to time, the Company reviews its disclosure controls and procedures, and may from time to time make changes aimed at enhancing their effectiveness and to ensure that the Company’s systems evolve with its business.

There was no change in the Company's internal control over financial reporting that occurred during the quarter ended October 3, 2021 that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting. We have considered the impact of COVID-19 on our internal controls over financial reporting. Personnel constraints related to working from home have made our ability to execute certain controls more challenging; however, we have enhanced existing monitoring controls in an effort to ensure we continue to have effective internal controls during this time.

30

PART II: OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Various claims and legal proceedings generally incidental to the normal course of business are pending or threatened on behalf of or against the Company. While we cannot predict the outcome of these matters, we believe that any liability arising from them will not have a material adverse effect on our financial position, liquidity, or results of operations.

ITEM 1A. RISK FACTORS

For a list of factors that could affect the Company’s business, results of operations, and financial condition, see the risk factors discussion provided in Part I—Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table sets forth information with respect to purchases by the Company of shares of its common stock during the three-month period ended October 3, 2021:

	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1)	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (1)
July 5, 2021 - August 1, 2021	54,000	$	84.64	54,000	$	253,216,000
August 2, 2021 - August 29, 2021	86,000	85.53		86,000	245,817,000
August 30, 2021 - October 3, 2021	183,000	84.70		183,000	230,357,000
Total	323,000	$	84.91	323,000	$	230,357,000

(1) In October 2018, the Company's Board of Directors authorized the repurchase of $200,000,000 of the Company's common stock. Purchases under this program commenced in October 2018. On March 12, 2020, the Company's Board of Directors authorized the repurchase of an additional $200,000,000 of the Company's common stock. This new authorization will commence once the Company completes the October 2018 program, with repurchases subject to market conditions and other relevant factors. The Company is authorized to make repurchases of its common stock through open market purchases, pursuant to Rule 10b5-1 trading plans, or in privately negotiated transactions.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

31

 ITEM 6. EXHIBITS

Exhibit Number
31.1	Certification of Principal Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934*
31.2	Certification of Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934*
32.1	Certification of Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
32.2	Certification of Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
101.SCH	Inline XBRL Taxonomy Extension Schema Document*
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document*
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document*
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document*
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document*
104	Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101.*)
*	Filed herewith
**	Furnished herewith

32

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date:	November 4, 2021	COGNEX CORPORATION
		By:	/s/ Robert J. Willett
			Robert J. Willett
			President and Chief Executive Officer
			(Principal Executive Officer)
		By:	/s/ Paul D. Todgham
			Paul D. Todgham
			Senior Vice President of Finance and Chief Financial Officer
			(Principal Financial Officer)

33

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Robert J. Willett, certify that:

1    I have reviewed this quarterly report on Form 10-Q of Cognex Corporation;

2    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4    The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5    The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	November 4, 2021	By:	/s/ Robert J. Willett
			Robert J. Willett
			President and Chief Executive Officer
			(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Paul D. Todgham, certify that:

1    I have reviewed this quarterly report on Form 10-Q of Cognex Corporation;

2    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4    The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5    The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	November 4, 2021	By:	/s/ Paul D. Todgham
			Paul D. Todgham
			Senior Vice President of Finance and Chief Financial Officer
			(Principal Financial Officer)

EX-32.1

Exhibit 32.1*

CERTIFICATION PURSUANT TO

18 U.S.C. 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned officer of Cognex Corporation (the “Company”) hereby certifies to his knowledge that the Company’s quarterly report on Form 10-Q for the quarterly period ended October 3, 2021 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	November 4, 2021	By:	/s/ Robert J. Willett
			Robert J. Willett
			President and Chief Executive Officer
			(Principal Executive Officer)

* This certification shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.

EX-32.2

Exhibit 32.2*

CERTIFICATION PURSUANT TO

18 U.S.C. 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned officer of Cognex Corporation (the “Company”) hereby certifies to his knowledge that the Company’s quarterly report on Form 10-Q for the quarterly period ended October 3, 2021 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	November 4, 2021	By:	/s/ Paul D. Todgham
			Paul D. Todgham
			Senior Vice President of Finance and Chief Financial Officer
			(Principal Financial Officer)

* This certification shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.

XML

Cover Page	9 Months Ended
	Oct. 03, 2021 shares
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 03, 2021
Document Transition Report	false
Entity File Number	001-34218
Entity Registrant Name	COGNEX CORP
Entity Central Index Key	0000851205
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Incorporation, State or Country Code	MA
Entity Tax Identification Number	04-2713778
Entity Address, Address Line One	One Vision Drive
Entity Address, City or Town	Natick
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	01760
City Area Code	508
Local Phone Number	650-3000
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Title of 12(b) Security	Common Stock, par value $.002 per share
Trading Symbol	CGNX
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding	176,799,003

XML

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020	Oct. 03, 2021	Sep. 27, 2020
Income Statement [Abstract]
Revenue	$ 284,848	$ 251,073	$ 793,033	$ 587,405
Cost of revenue	85,712	59,741	208,189	151,261
Gross margin	199,136	191,332	584,844	436,144
Research, development, and engineering expenses	34,476	30,240	99,883	96,583
Selling, general, and administrative expenses	77,113	64,206	226,380	193,497
Restructuring charges (Note 16)	0	251	0	15,049
Intangible asset impairment charges (Note 8)	0	0	0	19,571
Operating income	87,547	96,635	258,581	111,444
Foreign currency gain (loss)	(586)	2,357	(2,233)	(310)
Investment income	1,748	2,490	5,025	11,010
Other income (expense)	(125)	(173)	(420)	(153)
Income before income tax expense	88,584	101,309	260,953	121,991
Income tax expense	9,684	13,803	34,607	15,150
Net Income	$ 78,900	$ 87,506	$ 226,346	$ 106,841
Net income per weighted-average common and common-equivalent share:
Basic (usd per share)	$ 0.45	$ 0.50	$ 1.28	$ 0.62
Diluted (usd per share)	$ 0.44	$ 0.49	$ 1.26	$ 0.61
Weighted-average common and common-equivalent shares outstanding:
Basic (shares)	176,812	173,943	176,572	172,881
Diluted (shares)	180,342	177,138	180,109	176,038
Cash dividends per common share (usd per share)	$ 0.060	$ 0.055	$ 0.180	$ 0.165

XML

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020	Oct. 03, 2021	Sep. 27, 2020
Statement of Comprehensive Income [Abstract]
Net income	$ 78,900	$ 87,506	$ 226,346	$ 106,841
Available-for-sale investments:
Net unrealized gain (loss) on available-for-sale investments, net of tax	(521)	(2,308)	(2,617)	6,282
Reclassification of credit loss (recovery) on investments into current operations	0	0	0	75
Reclassification of net realized (gain) loss on the sale of available-for-sale investments into current operations	(19)	(786)	(87)	(3,591)
Net change related to available-for-sale investments	(540)	(3,094)	(2,704)	2,766
Foreign currency translation adjustments:
Foreign currency translation adjustments	(2,136)	2,098	(5,243)	(3,364)
Other comprehensive income (loss), net of tax	(2,676)	(996)	(7,947)	(598)
Total comprehensive income	$ 76,224	$ 86,510	$ 218,399	$ 106,243

XML

Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020	Oct. 03, 2021	Sep. 27, 2020
Statement of Comprehensive Income [Abstract]
Tax effect of unrealized gain (loss) on available-for-sale investments	$ (162)	$ 2,855	$ (808)	$ 1,067

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 03, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 203,479	$ 269,073
Current investments, amortized cost of $188,349 and $102,258 in 2021 and 2020, respectively, allowance for credit losses of $0 in 2021 and 2020	189,113	103,240
Accounts receivable, allowance for credit losses of $792 and $831 in 2021 and 2020, respectively	129,784	125,696
Unbilled revenue	7,325	5,632
Inventories	81,170	60,830
Prepaid expenses and other current assets	61,196	37,220
Total current assets	672,067	601,691
Non-current investments, amortized cost of $591,378 and $390,417 in 2021 and 2020, respectively, allowance for credit losses of $0 in 2021 and 2020	592,794	395,125
Property, plant, and equipment, net	76,882	79,173
Operating lease assets	24,154	22,582
Goodwill	241,799	244,078
Intangible assets, net	12,782	15,555
Deferred income taxes	420,962	434,704
Other assets	7,363	7,794
Total assets	2,048,803	1,800,702
Current liabilities:
Accounts payable	26,797	16,270
Accrued expenses	80,337	77,264
Accrued income taxes	12,271	9,379
Deferred revenue and customer deposits	37,843	21,274
Operating lease liabilities	7,889	8,110
Total current liabilities	165,137	132,297
Non-current operating lease liabilities	18,922	18,120
Deferred income taxes	302,019	314,952
Reserve for income taxes	14,805	14,257
Non-current accrued income taxes	40,963	48,915
Other liabilities	13,996	9,959
Total liabilities	555,842	538,500
Shareholders’ equity:
Preferred stock, $.01 par value – Authorized: 400 shares in 2021 and 2020, respectively, no shares issued and outstanding	0	0
Common stock, $.002 par value – Authorized: 300,000 shares in 2021 and 2020, respectively, issued and outstanding: 176,799 and 175,790 shares in 2021 and 2020, respectively	354	352
Additional paid-in capital	900,190	807,739
Retained earnings	634,165	487,912
Accumulated other comprehensive loss, net of tax	(41,748)	(33,801)
Total shareholders’ equity	1,492,961	1,262,202
Total liabilities and shareholders' equity	$ 2,048,803	$ 1,800,702

XML

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Oct. 03, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Amortized cost of current investments	$ 188,349	$ 102,258
Allowance for credit losses	0	0
Allowance for credit losses, current	792	831
Amortized cost of non-current investments	591,378	390,417
Allowance for credit losses, non-current	$ 0	$ 0
Preferred stock par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock shares authorized (in shares)	400,000	400,000
Preferred stock shares issued (in shares)	0	0
Preferred stock shares outstanding (in shares)	0	0
Common stock par value (in dollars per share)	$ 0.002	$ 0.002
Common stock shares authorized (in shares)	300,000,000	300,000,000
Common stock, shares issued (in shares)	176,799,000	175,790,000
Common stock, shares outstanding (in shares)	176,799,000	175,790,000

XML

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020
Cash flows from operating activities:
Net income	$ 226,346	$ 106,841
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	33,353	32,076
Depreciation of property, plant, and equipment	12,641	16,467
Loss on disposal of property, plant, and equipment	4	1,654
Amortization of intangible assets	2,773	3,437
Intangible asset impairment charges	0	19,571
Excess and obsolete inventory charges	2,120	9,386
Operating lease asset impairment charges	0	2,534
Amortization of discounts or premiums on investments	3,316	765
Realized gain on sale of investments	(87)	(3,591)
Credit loss on investments	0	75
Revaluation of contingent consideration	0	(114)
Change in deferred income taxes	1,411	3,194
Accounts receivable	(4,295)	(23,878)
Unbilled revenue	(1,689)	(10,606)
Inventories	(22,534)	(3,065)
Prepaid expenses and other current assets	(24,607)	(10,718)
Accounts payable	10,576	3,587
Accrued expenses	4,416	17,028
Accrued income taxes	(4,936)	(23,627)
Deferred revenue and customer deposits	16,751	19,066
Other	3,297	(632)
Net cash provided by operating activities	258,856	159,450
Cash flows from investing activities:
Purchases of investments	(607,458)	(601,447)
Maturities and sales of investments	317,174	567,245
Purchases of property, plant, and equipment	(10,689)	(9,829)
Net cash provided by (used in) investing activities	(300,973)	(44,031)
Cash flows from financing activities:
Net proceeds from issuance of common stock under stock plans	59,101	91,390
Repurchase of common stock	(48,294)	(51,036)
Payment of dividends	(31,800)	(28,554)
Payment of contingent consideration	0	(1,039)
Net cash provided by (used in) financing activities	(20,993)	10,761
Effect of foreign exchange rate changes on cash and cash equivalents	(2,484)	745
Net change in cash and cash equivalents	(65,594)	126,925
Cash and cash equivalents at beginning of period	269,073	171,431
Cash and cash equivalents at end of period	$ 203,479	$ 298,356

XML

Consolidated Statement of Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning Balance at Dec. 31, 2019	$ 1,355,710	$ 345	$ 639,372	$ 753,268	$ (37,275)
Beginning Balance (in shares) at Dec. 31, 2019		172,440
Increase (Decrease) in Stockholders' Equity
Net issuance of common stock under stock plans	91,390	$ 6	91,384
Issuance of common stock under stock plans (in shares)		3,408
Repurchase of common stock	(51,036)	$ (2)		(51,034)
Repurchase of common stock (in shares)		(1,215)
Stock-based compensation expense	32,076		32,076
Payment of dividends	(28,554)			(28,554)
Net income	106,841			106,841
Net unrealized gain (loss) on available-for-sale investments, net of tax	6,282				6,282
Reclassification of credit loss (recovery) on investments	75				75
Reclassification of net realized (gain) loss on the sale of available-for-sale investments	(3,591)				(3,591)
Foreign currency translation adjustment	(3,364)				(3,364)
Ending Balance (in shares) at Sep. 27, 2020		174,633
Ending Balance at Sep. 27, 2020	1,505,829	$ 349	762,832	780,521	(37,873)
Beginning Balance at Jun. 28, 2020	1,376,478	$ 346	710,412	702,597	(36,877)
Beginning Balance (in shares) at Jun. 28, 2020		173,047
Increase (Decrease) in Stockholders' Equity
Net issuance of common stock under stock plans	43,155	$ 3	43,152
Issuance of common stock under stock plans (in shares)		1,586
Stock-based compensation expense	9,268		9,268
Payment of dividends	(9,582)			(9,582)
Net income	87,506			87,506
Net unrealized gain (loss) on available-for-sale investments, net of tax	(2,308)				(2,308)
Reclassification of net realized (gain) loss on the sale of available-for-sale investments	(786)				(786)
Foreign currency translation adjustment	2,098				2,098
Ending Balance (in shares) at Sep. 27, 2020		174,633
Ending Balance at Sep. 27, 2020	1,505,829	$ 349	762,832	780,521	(37,873)
Beginning Balance at Dec. 31, 2020	$ 1,262,202	$ 352	807,739	487,912	(33,801)
Beginning Balance (in shares) at Dec. 31, 2020	175,790	175,790
Increase (Decrease) in Stockholders' Equity
Net issuance of common stock under stock plans	$ 59,101	$ 3	59,098
Issuance of common stock under stock plans (in shares)		1,590
Repurchase of common stock	(48,294)	$ (1)		(48,293)
Repurchase of common stock (in shares)		(581)
Stock-based compensation expense	33,353		33,353
Payment of dividends	(31,800)			(31,800)
Net income	226,346			226,346
Net unrealized gain (loss) on available-for-sale investments, net of tax	(2,617)				(2,617)
Reclassification of net realized (gain) loss on the sale of available-for-sale investments	(87)				(87)
Foreign currency translation adjustment	$ (5,243)				(5,243)
Ending Balance (in shares) at Oct. 03, 2021	176,799	176,799
Ending Balance at Oct. 03, 2021	$ 1,492,961	$ 354	900,190	634,165	(41,748)
Beginning Balance at Jul. 04, 2021	1,429,454	$ 353	874,883	593,290	(39,072)
Beginning Balance (in shares) at Jul. 04, 2021		176,707
Increase (Decrease) in Stockholders' Equity
Net issuance of common stock under stock plans	14,694	$ 1	14,693
Issuance of common stock under stock plans (in shares)		415
Repurchase of common stock	(27,417)	$ 0		(27,417)
Repurchase of common stock (in shares)		(323)
Stock-based compensation expense	10,614		10,614
Payment of dividends	(10,608)			(10,608)
Net income	78,900			78,900
Net unrealized gain (loss) on available-for-sale investments, net of tax	(521)				(521)
Reclassification of net realized (gain) loss on the sale of available-for-sale investments	(19)				(19)
Foreign currency translation adjustment	$ (2,136)				(2,136)
Ending Balance (in shares) at Oct. 03, 2021	176,799	176,799
Ending Balance at Oct. 03, 2021	$ 1,492,961	$ 354	$ 900,190	$ 634,165	$ (41,748)

XML

Consolidated Statement of Shareholders' Equity (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020	Oct. 03, 2021	Sep. 27, 2020
Statement of Stockholders' Equity [Abstract]
Cash dividends per common share (usd per share)	$ 0.060	$ 0.055	$ 0.180	$ 0.165
Tax effect of unrealized gain (loss) on available-for-sale investments	$ (162)	$ 2,855	$ (808)	$ 1,067

XML

Summary of Significant Accounting Policies

9 Months Ended

Oct. 03, 2021

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

As permitted by the rules of the Securities and Exchange Commission applicable to Quarterly Reports on Form 10-Q, these notes are condensed and do not contain all disclosures required by generally accepted accounting principles (GAAP). Reference should be made to the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 for a full description of other significant accounting policies.

In the opinion of the management of Cognex Corporation (the "Company"), the accompanying consolidated unaudited financial statements contain all adjustments, consisting of normal, recurring adjustments, excess and obsolete inventory charges (Note 5), intangible asset impairment charges (Note 8), restructuring charges (Note 16) and financial statement reclassifications necessary to present fairly the Company’s financial position as of October 3, 2021, and the results of its operations for the three-month and nine-month periods ended October 3, 2021 and September 27, 2020, and changes in shareholders’ equity, comprehensive income, and cash flows for the periods presented.

The results disclosed in the Consolidated Statements of Operations for the three-month and nine-month periods ended October 3, 2021 are not necessarily indicative of the results to be expected for the full year.

XML

New Pronouncements

9 Months Ended

Oct. 03, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

New Pronouncements

New Pronouncements

Accounting Standards Update (ASU) 2019-12, "Simplifying the Accounting for Income Taxes"

The amendments in this ASU eliminate certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. They also clarify and simplify other aspects of the accounting for income taxes. The Company adopted ASU 2019-12 on January 1, 2021. Upon adoption, ASU 2019-12 did not have a material impact on the Company's consolidated financial statements and disclosures.

Accounting Standards Update (ASU) 2020-08, "Codification Improvements to Subtopic 310-20, Receivables - Nonrefundable Fees and Other Costs"

The amendments in this ASU clarify that for each reporting period, for callable debt with multiple call dates and call prices that may change at each call date, to the extent that the amortized cost basis of an individual callable debt security exceeds the amount repayable by the issuer at the next call date, the excess is amortized to the next call date. The Company adopted ASU 2020-08 on January 1, 2021. Upon adoption, ASU 2020-08 did not have a material impact on the Company's consolidated financial statements and disclosures.

Accounting Standards Update (ASU) 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting" and (ASU) 2021-01, "Reference Rate Reform (Topic 848): Scope"

The amendments in these ASUs apply to all entities that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. Together, the ASUs provide optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The expedients and exceptions provided by the amendments do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. The amendments in these ASUs are effective for all entities as of March 12, 2020 through December 31, 2022. Management does not expect ASU 2020-04 or ASU 2021-01 to have a material impact on the Company's consolidated financial statements and disclosures.

XML

Fair Value Measurements

9 Months Ended

Oct. 03, 2021

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements

Financial Assets and Liabilities that are Measured at Fair Value on a Recurring Basis

The following table summarizes the financial assets and liabilities required to be measured at fair value on a recurring basis as of October 3, 2021 (in thousands):

	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Unobservable Inputs (Level 3)
Assets:
Money market instruments	$	3,616	$	—	$	—
Corporate bonds	—		555,992		—
Treasury bills	—		114,998		—
Asset-backed securities	—		83,896		—
Agency bonds	—		18,966		—
Municipal bonds	—		6,966		—
Sovereign bonds	—		1,089		—
Economic hedge forward contracts	—		129		—
Liabilities:
Economic hedge forward contracts	—		88		—

The Company’s money market instruments are reported at fair value based upon the daily market price for identical assets in active markets, and are therefore classified as Level 1.

The Company’s debt securities and forward contracts are reported at fair value based on model-driven valuations in which all significant inputs are observable or can be derived from or corroborated by observable market data for substantially the full term of the asset or liability, and are therefore classified as Level 2. Management is responsible for estimating the fair value of these financial assets and liabilities, and in doing so, considers valuations provided by a large, third-party pricing service. For debt securities, this service maintains regular contact with market makers, brokers, dealers, and analysts to gather information on market movement, direction, trends, and other specific data. They use this information to structure yield curves for various types of debt securities and arrive at the daily valuations. The Company's forward contracts are typically traded or executed in over-the-counter markets with a high degree of pricing transparency. The market participants are generally large commercial banks.

The Company's contingent consideration liabilities are reported at fair value based upon probability-adjusted present values of the consideration expected to be paid using significant inputs that are not observable in the market, and are therefore classified as Level 3. Key assumptions used in these estimates include probability assessments with respect to the likelihood of achieving certain revenue milestones. The fair values of these contingent consideration liabilities were calculated using discount rates consistent with the level of risk of achievement, and are remeasured each reporting period.

The fair value of the contingent consideration liability related to the Company's acquisition of GVi Ventures, Inc. in 2017 was written down to zero in 2019 resulting from a lower level of revenue in the Americas' automotive industry, and the balance remains at zero as of October 3, 2021. The undiscounted potential outcomes related to future contingent consideration range from $0 to $2,500,000 based upon certain revenue levels through April of 2022.

Non-financial Assets that are Measured at Fair Value on a Non-recurring Basis

Non-financial assets, such as property, plant and equipment, operating lease assets, goodwill, and intangible assets, are required to be measured at fair value only when an impairment loss is recognized. The Company evaluates these long-lived assets for impairment whenever events or changes in circumstances, referred to as "triggering events," indicate the carrying value may not be recoverable. The adverse impact of the COVID-19 pandemic on our business in 2020 triggered a review of long-lived assets for potential impairment as of May 26, 2020, which resulted in operating lease asset impairment charges of $2,534,000 (refer to Notes 6 and 16) that were

included in "Restructuring charges" on the Consolidated Statements of Operations, and intangible asset impairment charges of $19,571,000 (refer to Note 8) in the second quarter of 2020. These fair value measurements were based upon the present values of future cash flows using significant inputs that were not observable in the market, and were therefore classified as Level 3.

No triggering event occurred in the nine-month period ended October 3, 2021 that would indicate a potential impairment of long-lived assets. However, the Company continues to monitor global economic conditions, as events or changes in circumstances could result in an impairment of long-lived assets in a future period.

XML

Cash, Cash Equivalents, and Investments

9 Months Ended

Oct. 03, 2021

Cash and Cash Equivalents [Abstract]

Cash, Cash Equivalents, and Investments

Cash, Cash Equivalents, and Investments

Cash, cash equivalents, and investments consisted of the following (in thousands):

	October 3, 2021		December 31, 2020
Cash	$	199,863	$	266,609
Money market instruments	3,616		2,464
Cash and cash equivalents	203,479		269,073
Treasury bills	87,014		35,403
Corporate bonds	69,844		32,714
Asset-backed securities	23,133		25,160
Municipal bonds	6,320		1,303
Agency bonds	2,802		—
Sovereign bonds	—		8,660
Current investments	189,113		103,240
Corporate bonds	486,148		203,428
Asset-backed securities	60,763		67,058
Treasury bills	27,984		96,458
Agency bonds	16,164		19,006
Sovereign bonds	1,089		3,440
Municipal bonds	646		5,735
Non-current investments	592,794		395,125
	$	985,386	$	767,438

Cash equivalents are highly liquid investments with insignificant interest rate risk and maturities of ninety days or less at the time of acquisition. Cash equivalents consist primarily of government and institutional money market funds; treasury bills consist of debt securities issued by the U.S. government; corporate bonds consist of debt securities issued by both domestic and foreign companies; asset-backed securities consist of debt securities collateralized by pools of receivables or loans with credit enhancement; municipal bonds consist of debt securities issued by state and local government entities; agency bonds consist of domestic or foreign obligations of government agencies and government-sponsored enterprises that have government backing; and sovereign bonds consist of direct debt issued by foreign governments. All of the Company's securities as of October 3, 2021 and December 31, 2020 were denominated in U.S. Dollars.

Accrued interest receivable is recorded in "Prepaid expenses and other current assets" on the Consolidated Balance Sheet and amounted to $3,481,000 and $1,560,000 as of October 3, 2021 and December 31, 2020, respectively.

The following table summarizes the Company’s available-for-sale investments as of October 3, 2021 (in thousands):

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Current:
Treasury bills	$	86,657	$	357	$	—	$	87,014
Corporate bonds	69,562		290		(8)		69,844
Asset-backed securities	22,990		147		(4)		23,133
Municipal bonds	6,340		3		(23)		6,320
Agency bonds	2,800		2		—		2,802
Non-current:
Corporate bonds	485,290		1,631		(773)		486,148
Asset-backed securities	60,418		346		(1)		60,763
Treasury bills	27,821		163		—		27,984
Agency bonds	16,124		40		—		16,164
Sovereign bonds	1,090		—		(1)		1,089
Municipal bonds	635		11		—		646
	$	779,727	$	2,990	$	(810)	$	781,907

The following table summarizes the Company’s gross unrealized losses and fair values for available-for-sale investments in an unrealized loss position as of October 3, 2021 (in thousands):

	Unrealized Loss Position For:
	Less than 12 Months				12 Months or Greater				Total
	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Corporate bonds	$	216,480	$	(781)	$	—	$	—	$	216,480	$	(781)
Municipal bonds	3,917		(23)		—		—		3,917		(23)
Asset-backed securities	3,732		(5)		—		—		3,732		(5)
Sovereign bonds	1,089		(1)		—		—		1,089		(1)
	$	225,218	$	(810)	$	—	$	—	$	225,218	$	(810)

The Company's allowance for credit losses on debt securities was zero as of October 3, 2021 and December 31, 2020. There was no activity recorded in the allowance for credit losses during the three-month and nine-month periods ended October 3, 2021. The Company recorded no gross credit losses or gross credit recoveries for the three-month period ended September 27, 2020, and gross credit losses of $160,000 and gross credit recoveries of $85,000 for the nine-month period ended September 27, 2020.

The Company recorded gross realized gains on the sale of debt securities totaling $19,000 and $87,000 for the three-month and nine-month periods ended October 3, 2021, respectively, and no gross realized losses on the sale of debt securities for the three-month and nine-month periods ended October 3, 2021. The Company recorded gross realized gains on the sale of debt securities totaling $787,000 and $3,613,000 for the three-month and nine-month periods ended September 27, 2020, respectively, and gross realized losses on the sale of debt securities totaling $1,000 and $22,000, respectively, for the three-month and nine-month periods ended September 27, 2020. These gains and losses are included in "Investment income" on the Consolidated Statements of Operations. Prior to the sale of these securities, unrealized gains and losses for these debt securities, net of tax, are recorded in shareholders’ equity as accumulated other comprehensive loss.

The following table presents the effective maturity dates of the Company’s available-for-sale investments as of October 3, 2021 (in thousands):

	<1 year		1-2 Years		2-3 Years		3-4 Years		4-5 Years		Total
Corporate bonds	$	69,844	$	192,354	$	151,615	$	94,993	$	47,186	$	555,992
Treasury bills	87,014		27,984		—		—		—		114,998
Asset-backed securities	23,133		41,115		6,217		13,431		—		83,896
Agency bonds	2,802		16,164		—		—		—		18,966
Municipal bonds	6,320		646		—		—		—		6,966
Sovereign bonds	—		—		—		—		1,089		1,089
	$	189,113	$	278,263	$	157,832	$	108,424	$	48,275	$	781,907

XML

Inventories

9 Months Ended

Oct. 03, 2021

Inventory Disclosure [Abstract]

Inventories

Inventories

Inventories consisted of the following (in thousands):

	October 3, 2021		December 31, 2020
Raw materials	$	32,598	$	26,800
Work-in-process	2,975		4,780
Finished goods	45,597		29,250
	$	81,170	$	60,830

The Company recorded provisions for excess and obsolete inventories of $304,000 and $2,120,000 for the three-month and nine-month periods ended October 3, 2021, respectively, and $603,000 and $9,386,000 for the three-month and nine-month periods ended September 27, 2020, respectively, which reduced the carrying value of the inventories to their net realizable value. Estimates in 2020 took into account the global economic conditions resulting from the COVID-19 pandemic.

XML

Leases

9 Months Ended

Oct. 03, 2021

Leases [Abstract]

Leases

Leases

The Company's leases are primarily leased properties across different worldwide locations where the Company conducts its operations. All of these leases are classified as operating leases. Certain leases may contain options to extend or terminate the lease at the Company's sole discretion. There were no options to extend or terminate that were included in the determination of the lease term for the leases outstanding as of October 3, 2021. Certain leases contain leasehold improvement incentives, retirement obligations, escalating clauses, rent holidays, and variable payments tied to a consumer price index. There were no restrictions or covenants for outstanding leases as of October 3, 2021.

The total operating lease expense for the three-month and nine-month periods ended October 3, 2021 was $2,068,000 and $6,091,000, respectively. The total operating lease cash payments for the three-month and nine-month periods ended October 3, 2021 were $2,079,000 and $6,154,000, respectively. The total lease expense for leases with a term of twelve months or less for which the Company elected not to recognize a lease asset or lease liability for the three-month and nine-month periods ended October 3, 2021 was $36,000 and $114,000, respectively.

The total operating lease expense for the three-month and nine-month periods ended September 27, 2020 was $2,047,000 and $6,100,000, respectively. The total operating lease cash payments for the three-month and nine-month periods ended September 27, 2020 were $2,041,000 and $5,995,000, respectively. The total lease expense for leases with a term of twelve months or less for which the Company elected not to recognize a lease asset or lease liability for the three-month and nine-month periods ended September 27, 2020 was $22,000 and $84,000, respectively.

Future operating lease cash payments are as follows (in thousands):

Year Ended December 31,	Amount
Remainder of fiscal 2021	$	2,348
2022	8,221
2023	6,588
2024	3,526
2025	2,033
2026	1,297
Thereafter	5,160
	$	29,173

The discounted present value of the future lease cash payments resulted in a lease liability of $26,811,000 and $26,230,000 as of October 3, 2021 and December 31, 2020, respectively. The Company did not have any leases that had not yet commenced but that created significant rights and obligations as of October 3, 2021 or December 31, 2020.

The weighted-average discount rate was 3.5% and 4.0% for the leases outstanding as of October 3, 2021 and December 31, 2020, respectively. The weighted-average remaining lease term was 5.2 and 5.1 years for the leases outstanding as of October 3, 2021 and December 31, 2020, respectively.

Management closed eleven leased offices in 2020, prior to the end of their lease terms, as a part of the Company's restructuring plan (refer to Note 16). The carrying value of the lease assets associated with the majority of these offices was reduced to zero, resulting in operating lease asset impairment charges of $2,534,000 in the second quarter of 2020 that are included in "Restructuring charges" on the Consolidated Statements of Operations. Management is currently negotiating early contract terminations for the remaining lease liability obligations associated with these abandoned offices, which obligations totaled $2,019,000 and $2,877,000 as of October 3, 2021 and December 31, 2020, respectively, and are included in "Operating lease liabilities" on the Consolidated Balance Sheets.

XML

Goodwill

9 Months Ended

Oct. 03, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

Goodwill

The changes in the carrying value of goodwill were as follows (in thousands):

Balance as of December 31, 2020	$	244,078
Foreign exchange rate changes	(2,279)
Balance as of October 3, 2021	$	241,799

The adverse impact of the COVID-19 pandemic on our business in 2020 triggered a review of long-lived assets, including goodwill, for potential impairment during the second quarter of 2020. Based on this assessment, management concluded that events and circumstances did not indicate the fair value of the reporting unit was less than its carrying value. Factors that management considered in this qualitative assessment included macroeconomic conditions, industry and market considerations, overall financial performance (both current and projected), changes in management or strategy, changes in the composition or carrying amount of net assets, and market capitalization.

XML

Intangible Assets

9 Months Ended

Oct. 03, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

Intangible Assets

Amortized intangible assets consisted of the following (in thousands):

	Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Distribution networks	$	38,060	$	38,060	$	—
Completed technologies	24,217		14,548		9,669
Customer relationships	10,578		7,700		2,878
Non-compete agreements	710		478		232
Trademarks	110		107		3
Balance as of October 3, 2021	$	73,675	$	60,893	$	12,782
	Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Distribution networks	$	38,060	$	38,060	$	—
Completed technologies	24,217		12,397		11,820
Customer relationships	10,578		7,160		3,418
Non-compete agreements	710		436		274
Trademarks	110		67		43
Balance as of December 31, 2020	$	73,675	$	58,120	$	15,555

As of October 3, 2021, estimated future amortization expense related to intangible assets was as follows (in thousands):

Year Ended December 31,	Amount
Remainder of fiscal 2021	$	883
2022	3,286
2023	2,594
2024	2,080
2025	1,757
2026	1,452
Thereafter	730
	$	12,782

The adverse impact of the COVID-19 pandemic on our business in 2020 triggered a review of long-lived assets, including intangible assets, for potential impairment during the second quarter of 2020. Based on this assessment, management concluded that certain of the Company's finite-lived intangible assets failed the recoverability test, and recorded impairment charges for these assets equal to the amount by which their carrying value exceeded their fair value. The Company also measured the fair value and recorded an impairment charge for its indefinite-lived intangible asset related to in-process technologies. The fair values were established, with the assistance of an outside valuation advisor, using the income approach based on a discounted cash flow model that estimated future revenue streams and expenses attributable to those revenue streams provided by management.

This review resulted in intangible asset impairment charges totaling $19,571,000 in the second quarter of 2020, primarily related to lower projected cash flows from the technologies and customer relationships acquired from Sualab Co. Ltd. ("Sualab") as a result of the deteriorating global economic conditions from the COVID-19 pandemic. Completed technologies, in-process technologies, and customer relationships acquired from Sualab were impaired in the amounts of $10,070,000, $5,900,000, and $3,382,000, respectively. In addition, customer relationships acquired from EnShape GmbH that had a gross carrying value of $447,000 and accumulated amortization of $228,000 on the measurement date were reduced to zero, resulting in an impairment charge of $219,000. The Company did not record impairment charges related to intangible assets during the three-month or nine-month periods ended October 3, 2021.

XML

Warranty Obligations

9 Months Ended

Oct. 03, 2021

Product Warranties Disclosures [Abstract]

Warranty Obligations

Warranty Obligations

The Company records the estimated cost of fulfilling product warranties at the time of sale based upon historical costs to fulfill claims. Obligations may also be recorded subsequent to the time of sale whenever specific events or changes in circumstances impacting product quality become known that would not have been taken into account using historical data. While we engage in extensive product quality programs and processes, including actively monitoring and evaluating the quality of our component suppliers and third-party contract manufacturers, the Company’s warranty obligation is affected by product failure rates, material usage, and service delivery costs incurred in correcting a product failure. An adverse change in any of these factors may result in the need for additional warranty provisions. Warranty obligations are included in “Accrued expenses” on the Consolidated Balance Sheets.

The changes in the warranty obligation were as follows (in thousands):

Balance as of December 31, 2020	$	5,406
Provisions for warranties issued during the period	2,528
Fulfillment of warranty obligations	(2,517)
Balance as of October 3, 2021	$	5,417

XML

Derivative Instruments

9 Months Ended

Oct. 03, 2021

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments

Derivative InstrumentsThe Company’s foreign currency risk management strategy is principally designed to mitigate the potential financial impact of changes in the value of transactions and balances denominated in foreign currencies resulting from changes in foreign currency exchange rates. The Company enters into economic hedges utilizing foreign currency forward contracts with maturities of up to 95 days to manage the exposure to fluctuations in foreign currency exchange rates arising primarily from foreign-denominated receivables and payables. The gains and losses on these derivatives are intended to be offset by the changes in the fair value of the assets and liabilities being hedged. These economic hedges are not designated as hedging instruments for hedge accounting treatment.

The Company had the following outstanding forward contracts (in thousands):

	October 3, 2021			December 31, 2020
Currency	Notional Value	USD Equivalent		Notional Value	USD Equivalent
Derivatives Not Designated as Hedging Instruments:
Euro	38,500	$	44,687	50,000	$	61,342
Chinese Renminbi	55,069	8,500		—	—
Mexican Peso	120,000	5,823		155,000	7,776
Korean Won	6,770,000	5,714		6,925,000	6,377
Japanese Yen	600,000	5,405		600,000	5,808
British Pound	3,115	4,224		1,675	2,287
Hungarian Forint	1,235,000	3,992		1,330,000	4,494
Taiwanese Dollar	45,405	1,637		38,035	1,362
Singapore Dollar	1,800	1,328		1,465	1,110
Canadian Dollar	1,370	1,080		1,285	1,010

Information regarding the fair value of the outstanding forward contracts was as follows (in thousands):

	Asset Derivatives					Liability Derivatives
	Balance	Fair Value				Balance	Fair Value
	Sheet Location	October 3, 2021		December 31, 2020		Sheet Location	October 3, 2021		December 31, 2020
Derivatives Not Designated as Hedging Instruments:
Economic hedge forward contracts	Prepaid expenses and other current assets	$	129	$	265	Accrued expenses	$	88	$	38

The following table presents the gross activity for all derivative assets and liabilities which were presented on a net basis on the Consolidated Balance Sheets due to the right of offset with each counterparty (in thousands):

Asset Derivatives					Liability Derivatives
	October 3, 2021		December 31, 2020			October 3, 2021		December 31, 2020
Gross amounts of recognized assets	$	129	$	265	Gross amounts of recognized liabilities	$	88	$	38
Gross amounts offset	—		—		Gross amounts offset	—		—
Net amount of assets presented	$	129	$	265	Net amount of liabilities presented	$	88	$	38

Information regarding the effect of derivative instruments on the consolidated financial statements was as follows (in thousands):

	Location in Financial Statements	Three-months Ended				Nine-months Ended
		October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
Derivatives Not Designated as Hedging Instruments:
Gains (losses) recognized in current operations	Foreign currency gain (loss)	$	1,529	$	(1,521)	$	3,676	$	(9,701)

XML

Revenue Recognition

9 Months Ended

Oct. 03, 2021

Revenue from Contract with Customer [Abstract]

Revenue Recognition

Revenue Recognition

The following table summarizes disaggregated revenue information by geographic area based upon the customer's country of domicile (in thousands):

	Three-months Ended				Nine-months Ended
	October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
Americas	$	113,758	$	86,482	$	330,012	$	215,696
Europe	65,146		60,189		182,161		144,758
Greater China	65,813		77,292		163,757		135,593
Other Asia	40,131		27,110		117,103		91,358
	$	284,848	$	251,073	$	793,033	$	587,405

The following table summarizes disaggregated revenue information by revenue type (in thousands):

	Three-months Ended				Nine-months Ended
	October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
Standard products and services	$	212,567	$	174,797	$	669,215	$	486,458
Application-specific customer solutions	72,281		76,276		123,818		100,947
	$	284,848	$	251,073	$	793,033	$	587,405

Costs to Fulfill a Contract

Costs to fulfill a contract are included in "Prepaid expenses and other current assets" on the Consolidated Balance Sheet and amounted to $13,308,000 and $6,846,000 as of October 3, 2021 and December 31, 2020, respectively.

Accounts Receivable, Contract Assets, and Contract Liabilities

Accounts receivable represent amounts billed and currently due from customers which are reported at their net estimated realizable value. The Company maintains an allowance against its accounts receivable for credit losses. Contract assets consist of unbilled revenue which arises when revenue is recognized in advance of billing for certain application-specific customer solutions contracts. Contract liabilities consist of deferred revenue and customer deposits which arise when amounts are billed to or collected from customers in advance of revenue recognition.

The following table summarizes the allowance for credit losses activity for the nine-month period ended October 3, 2021 (in thousands):

Balance as of December 31, 2020	$	831
Increases to the allowance for credit losses	—
Write-offs, net of recoveries	(39)
Foreign exchange rate changes	—
Balance as of October 3, 2021	$	792

The following table summarizes the deferred revenue and customer deposits activity for the nine-month period ended October 3, 2021 (in thousands):

Balance as of December 31, 2020	$	21,274
Deferral of revenue billed in the current period, net of recognition	33,888
Recognition of revenue deferred in prior period	(17,130)
Foreign exchange rate changes	(189)
Balance as of October 3, 2021	$	37,843

As a practical expedient, the Company has elected not to disclose the aggregate amount of the transaction price allocated to unsatisfied performance obligations, as our contracts have an original expected duration of less than one year.

XML

Stock-Based Compensation Expense

9 Months Ended

Oct. 03, 2021

Share-based Payment Arrangement [Abstract]

Stock-Based Compensation Expense

Stock-Based Compensation Expense

Stock Plans

The Company’s stock-based awards that result in compensation expense consist of stock options and restricted stock units ("RSUs"). As of October 3, 2021, the Company had 15,661,000 shares available for grant under its stock plans. Stock options are granted with an exercise price equal to the market value of the Company’s common stock at the grant date and generally vest over four or five years based upon continuous service and expire ten years from the grant date. RSUs generally vest upon three years of continuous employment or incrementally over such three-year period. Participants are not entitled to dividends on RSUs.

Stock Options

The following table summarizes the Company’s stock option activity for the nine-month period ended October 3, 2021:

	Shares (in thousands)	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of December 31, 2020	8,970	$	44.73
Granted	549	88.80
Exercised	(1,582)	37.70
Forfeited or expired	(225)	50.29
Outstanding as of October 3, 2021	7,712	$	49.15	6.79	$	252,476
Exercisable as of October 3, 2021	3,290	$	39.03	5.56	$	139,215
Options vested or expected to vest as of October 3, 2021 (1)	7,157	$	48.36	6.70	$	239,568

 (1) In addition to the vested options, the Company expects a portion of the unvested options to vest at some point in the future. Options expected to vest are calculated by applying an estimated forfeiture rate to the unvested options.

The fair values of stock options granted in each period presented were estimated using the following weighted-average assumptions:

	Three-months Ended				Nine-months Ended
	October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
Risk-free rate	1.4	%	—	%	1.3	%	1.6	%
Expected dividend yield	0.28	%	—	%	0.27	%	0.43	%
Expected volatility	39	%	—	%	39	%	37	%
Expected term (in years)	7.1		—		6.0		6.0

No stock options were granted during the three-month period ended September 27, 2020.

Risk-free rate

The risk-free rate was based upon a treasury instrument whose term was consistent with the contractual term of the option.

Expected dividend yield

Generally, the current dividend yield is calculated by annualizing the cash dividend declared by the Company’s Board of Directors and dividing that result by the closing stock price on the grant date. 

Expected volatility

The expected volatility was based upon a combination of historical volatility of the Company’s common stock over the contractual term of the option and implied volatility for traded options of the Company’s stock.

Expected term

The expected term was derived from the binomial lattice model from the impact of events that trigger exercises over time.

The weighted-average grant-date fair values of stock options granted during the three-month and nine-month periods ended October 3, 2021 were $35.64 and $33.78, respectively, and during the nine-month period ended September 27, 2020 was $18.52. There were no stock options granted during the three-month period ended September 27, 2020.

The total intrinsic values of stock options exercised for the three-month and nine-month periods ended October 3, 2021 were $21,415,000 and $75,363,000, respectively, and for the three-month and nine-month periods ended September 27, 2020 were $62,787,000 and $116,600,000, respectively. The total fair values of stock options vested for the three-month and nine-month periods ended October 3, 2021 were $1,498,000 and $38,928,000, respectively, and for the three-month and nine-month periods ended September 27, 2020 were $1,331,000 and $39,282,000, respectively.

Restricted Stock Units (RSUs)

The following table summarizes the Company's RSUs activity for the nine-month period ended October 3, 2021:

	Shares (in thousands)	Weighted-Average Grant Date Fair Value
Nonvested as of December 31, 2020	554	$	51.27
Granted	318	87.38
Vested	(15)	56.61
Forfeited or expired	(43)	56.49
Nonvested as of October 3, 2021	814	$	65.01

The weighted-average grant-date fair values of RSUs granted during the three-month and nine-month periods ended October 3, 2021 were $86.34 and $87.38, respectively, and during the three-month and nine-month periods ended September 27, 2020 were $67.14 and $51.73, respectively. There were 15,000 RSUs that vested during the nine-month period ended October 3, 2021. There were no RSUs that vested during the three-month period ended October 3, 2021 or the three-month and nine-month periods ended September 27, 2020.

Stock-Based Compensation Expense

The Company segments its employee population into two groups: one consisting of senior management and another consisting of all other employees. The Company currently applies an estimated annual forfeiture rate of 8% to all stock-based awards for senior management and a rate of 12% for all other employees. Each year during the first quarter, the Company revises its forfeiture rate based on updated estimates of employee turnover. This resulted in a decrease to compensation expense of $255,000 in 2021 and an increase to compensation expense of $1,787,000 in 2020.

As of October 3, 2021, total unrecognized compensation expense related to non-vested equity awards, including stock options and RSUs, was $56,579,000, which is expected to be recognized over a weighted-average period of 1.6 years.

The total stock-based compensation expense and the related income tax benefit recognized for the three-month period ended October 3, 2021 were $10,614,000 and $1,637,000, respectively, and for the nine-month period ended October 3, 2021 were $33,353,000 and $5,101,000, respectively. The total stock-based compensation expense and the related income tax benefit recognized for the three-month period ended September 27, 2020 were $9,268,000 and $1,524,000, respectively, and for the nine-month period ended September 27, 2020 were $32,076,000 and $5,365,000, respectively. Stock-based compensation expense recognized for the three-month and nine-month periods ended September 27, 2020 included credits of $1,401,000 relating to grants cancelled as a result of the Company's workforce reduction in the second quarter of 2020. No compensation expense was capitalized as of October 3, 2021 or December 31, 2020.

The following table presents the stock-based compensation expense by caption for each period presented on the Consolidated Statements of Operations (in thousands):

	Three-months Ended				Nine-months Ended
	October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
Cost of revenue	$	366	$	324	$	965	$	1,041
Research, development, and engineering	3,091		2,815		10,158		10,582
Selling, general, and administrative	7,157		6,129		22,230		20,453
	$	10,614	$	9,268	$	33,353	$	32,076

XML

Stock Repurchase Program	9 Months Ended
	Oct. 03, 2021
Equity [Abstract]
Stock Repurchase Program	Stock Repurchase ProgramIn October 2018, the Company's Board of Directors authorized the repurchase of $200,000,000 of the Company's common stock. As of October 3, 2021, the Company repurchased 3,398,000 shares at a cost of $169,643,000 under this program, including 581,000 shares at a cost of $48,294,000 during the nine-month period ended October 3, 2021, leaving a remaining balance of $30,357,000. 1,215,000 shares at a cost of $51,036,000 were repurchased during the nine-month period ended September 27, 2020 under this October 2018 program. On March 12, 2020, the Company's Board of Directors authorized the repurchase of an additional $200,000,000 of the Company's common stock. Purchases under this March 2020 program will commence upon completion of the October 2018 program. The Company may repurchase shares under this program in future periods depending on a variety of factors, including, among other things, the impact of dilution from employee stock awards, stock price, share availability, and cash requirements. The Company is authorized to make repurchases of its common stock through open market purchases, pursuant to Rule 10b5-1 trading plans, or in privately negotiated transactions.

XML

Income Taxes

9 Months Ended

Oct. 03, 2021

Income Tax Disclosure [Abstract]

Income Taxes

Taxes

A reconciliation of the United States federal statutory corporate tax rate to the Company’s income tax expense, or effective tax rate, was as follows:

	Three-months Ended				Nine-months Ended
	October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
Income tax expense at U.S. federal statutory corporate tax rate	21	%	21	%	21	%	21	%
State income taxes, net of federal benefit	2	%	1	%	2	%	1	%
Foreign tax rate differential	(5)	%	(5)	%	(5)	%	(5)	%
Tax credit	(1)	%	(1)	%	(1)	%	(1)	%
Discrete tax benefit related to stock options	(4)	%	(4)	%	(4)	%	(9)	%
Discrete tax expense (benefit) related to tax return filings	(3)	%	—	%	(1)	%	3	%
Other	1	%	2	%	1	%	2	%
Income tax expense	11	%	14	%	13	%	12	%

The Company recorded discrete tax benefits arising from the difference between the deduction for tax purposes and the compensation cost recognized for financial reporting purposes from stock option exercises that resulted in a favorable impact to the effective tax rate of 4% for both the three-month and nine-month periods ended October 3, 2021, and 4% and 9% for the three-month and nine-month periods ended September 27, 2020, respectively. In addition to stock option exercises, other discrete adjustments recorded included the final true-up of the prior year's tax accrual upon filing the related tax return that resulted in a favorable impact to the effective tax rate of 3% and 1% for the three-month and nine-month periods ended October 3, 2021, respectively, and an unfavorable impact to the effective tax rate of 3% for the nine-month period ended September 27, 2020.

Excluding the impact of these discrete items, the Company’s effective tax rate was 18% of pre-tax income for the three-month and nine-month periods ended October 3, 2021, and 18% of pre-tax income for the same periods in 2020.

During the nine-month period ended October 3, 2021, the Company recorded a $495,000 increase in reserves for income taxes, net of deferred tax benefit. Estimated interest and penalties included in these amounts totaled $450,000 for the nine-month period ended October 3, 2021.

The Company’s reserve for income taxes, including gross interest and penalties, was $15,833,000 as of October 3, 2021, which included $14,805,000 classified as a non-current liability and $1,028,000 recorded as a reduction to non-current deferred tax assets. If the Company’s tax positions were sustained or the statutes of limitations related to certain positions expired, these reserves would be released and income tax expense would be reduced in a future period. During the three-month period ending October 3, 2021, the Company released $648,000 in reserves related to statute expiration and tax return positions.

The Company has defined its major tax jurisdictions as the United States, Ireland, China, and Korea, and within the United States, Massachusetts. The statutory tax rate is 12.5% in Ireland, 25% in China, and 25% in Korea compared to the U.S. federal statutory corporate tax rate of 21%. These differences resulted in a favorable impact to the effective tax rate of 5% for both the three-month and nine-month periods ended October 3, 2021, and for the same periods in 2020.

Within the United States, the tax years 2017 through 2020 remain open to examination by the Internal Revenue Service ("IRS") and various state tax authorities. The tax years 2016 through 2020 remain open to examination by various taxing authorities in other jurisdictions in which the Company operates. The Company is under audit by the IRS for the tax years 2017 and 2018. Additionally, the Company is under audit by the Commonwealth of Massachusetts for tax years 2017 and 2018. Management believes the Company is adequately reserved for these audits. The final determination of tax audits could result in favorable or unfavorable changes in our estimates.

XML

Weighted-Average Shares

9 Months Ended

Oct. 03, 2021

Earnings Per Share [Abstract]

Weighted-Average Shares

Weighted-Average Shares

Weighted-average shares were calculated as follows (in thousands):

	Three-months Ended		Nine-months Ended
	October 3, 2021	September 27, 2020	October 3, 2021	September 27, 2020
Basic weighted-average common shares outstanding	176,812	173,943	176,572	172,881
Effect of dilutive equity awards	3,530	3,195	3,537	3,157
Weighted-average common and common-equivalent shares outstanding	180,342	177,138	180,109	176,038

Stock options to purchase 586,000 and 655,000 shares of common stock, on a weighted-average basis, were outstanding during the three-month and nine-month periods ended October 3, 2021, respectively, and 1,416,000 and 5,540,000 for the same periods in 2020, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 1,000 shares of common stock, on a weighted-average basis, were outstanding during both the three-month and nine-month periods ended October 3, 2021, respectively, and 3,000 and 2,000 for the same periods in 2020, but were not included in the calculation of dilutive net income per share because they were anti-dilutive.

XML

Restructuring Charges

9 Months Ended

Oct. 03, 2021

Restructuring and Related Activities [Abstract]

Restructuring Charges

Restructuring Charges

On May 26, 2020, the Company's Board of Directors approved a restructuring plan intended to reduce the Company's operating costs, optimize its business model, and address the impact of the COVID-19 pandemic. The restructuring plan included a global workforce reduction of approximately 8% and office closures.

As of December 31, 2020, the majority of these actions were completed and no additional charges are expected to be incurred in future periods in relation to this restructuring plan. There were no restructuring charges recognized during the three-month or nine-month periods ended October 3, 2021.

The following table summarizes the restructuring charges incurred in the three-month and nine-month periods ended September 27, 2020 (in thousands):

	Incurred in the Three-months Ended September 27, 2020		Incurred in the Nine-months Ended September 27, 2020
One-time termination benefits	$	(36)	$	10,350
Contract termination costs	104		4,099
Other associated costs	183		600
	$	251	$	15,049

One-time termination benefits included severance, health insurance, and outplacement services for 181 employees who were either terminated during the second quarter of 2020, or were notified during the second quarter of 2020 that they would be terminated at a future date. For employees not required to render service beyond a minimum retention period, the one-time termination benefits were recognized in the second quarter of 2020. Otherwise, these benefits, including retention bonuses for selected employees, were recognized over the service period, which was completed by December 31, 2020.

Contract termination costs included operating lease asset impairment charges for offices closed prior to the end of the contractual lease term. These costs also included the write-off of leasehold improvements and other equipment related to these abandoned offices that had no alternative use, as well as other associated operating costs, such as utilities, that the Company is obligated to pay for the remainder of the lease term. These contract termination costs were primarily recognized in the second quarter of 2020 when the Company ceased using the property for economic benefit.

Other associated costs primarily included legal fees related to the employee termination actions, which were recognized when the services were performed.

The following table summarizes the activity for the nine-month period ended October 3, 2021 in the Company’s restructuring reserve which is included in “Accrued expenses” on the Consolidated Balance Sheets (in thousands):

	One-time Termination Benefits		Contract Termination Costs		Other Associated Costs		Total
Balance as of December 31, 2020	$	1,624	$	750	$	15	$	2,389
Cash payments	(1,133)		(176)		(15)		(1,324)
Foreign exchange rate changes	—		(5)		—		(5)
Balance as of October 3, 2021	$	491	$	569	$	—	$	1,060

XML

Subsequent Events	9 Months Ended
	Oct. 03, 2021
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsOn November 4, 2021, the Company’s Board of Directors declared a cash dividend of $0.065 per share. The dividend is payable on December 3, 2021 to all shareholders of record as of the close of business on November 19, 2021.

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Oct. 03, 2021

Accounting Policies [Abstract]

New Pronouncements

New Pronouncements

Accounting Standards Update (ASU) 2019-12, "Simplifying the Accounting for Income Taxes"

The amendments in this ASU eliminate certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. They also clarify and simplify other aspects of the accounting for income taxes. The Company adopted ASU 2019-12 on January 1, 2021. Upon adoption, ASU 2019-12 did not have a material impact on the Company's consolidated financial statements and disclosures.

Accounting Standards Update (ASU) 2020-08, "Codification Improvements to Subtopic 310-20, Receivables - Nonrefundable Fees and Other Costs"

The amendments in this ASU clarify that for each reporting period, for callable debt with multiple call dates and call prices that may change at each call date, to the extent that the amortized cost basis of an individual callable debt security exceeds the amount repayable by the issuer at the next call date, the excess is amortized to the next call date. The Company adopted ASU 2020-08 on January 1, 2021. Upon adoption, ASU 2020-08 did not have a material impact on the Company's consolidated financial statements and disclosures.

Accounting Standards Update (ASU) 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting" and (ASU) 2021-01, "Reference Rate Reform (Topic 848): Scope"

The amendments in these ASUs apply to all entities that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. Together, the ASUs provide optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The expedients and exceptions provided by the amendments do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. The amendments in these ASUs are effective for all entities as of March 12, 2020 through December 31, 2022. Management does not expect ASU 2020-04 or ASU 2021-01 to have a material impact on the Company's consolidated financial statements and disclosures.

XML

Fair Value Measurements (Tables)

9 Months Ended

Oct. 03, 2021

Fair Value Disclosures [Abstract]

Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table summarizes the financial assets and liabilities required to be measured at fair value on a recurring basis as of October 3, 2021 (in thousands):

	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Unobservable Inputs (Level 3)
Assets:
Money market instruments	$	3,616	$	—	$	—
Corporate bonds	—		555,992		—
Treasury bills	—		114,998		—
Asset-backed securities	—		83,896		—
Agency bonds	—		18,966		—
Municipal bonds	—		6,966		—
Sovereign bonds	—		1,089		—
Economic hedge forward contracts	—		129		—
Liabilities:
Economic hedge forward contracts	—		88		—

XML

Cash, Cash Equivalents, and Investments (Tables)

9 Months Ended

Oct. 03, 2021

Cash and Cash Equivalents [Abstract]

Components of Cash, Cash Equivalents, and Investments

Cash, cash equivalents, and investments consisted of the following (in thousands):

	October 3, 2021		December 31, 2020
Cash	$	199,863	$	266,609
Money market instruments	3,616		2,464
Cash and cash equivalents	203,479		269,073
Treasury bills	87,014		35,403
Corporate bonds	69,844		32,714
Asset-backed securities	23,133		25,160
Municipal bonds	6,320		1,303
Agency bonds	2,802		—
Sovereign bonds	—		8,660
Current investments	189,113		103,240
Corporate bonds	486,148		203,428
Asset-backed securities	60,763		67,058
Treasury bills	27,984		96,458
Agency bonds	16,164		19,006
Sovereign bonds	1,089		3,440
Municipal bonds	646		5,735
Non-current investments	592,794		395,125
	$	985,386	$	767,438

Summary of Available-for-Sale Investments

The following table summarizes the Company’s available-for-sale investments as of October 3, 2021 (in thousands):

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Current:
Treasury bills	$	86,657	$	357	$	—	$	87,014
Corporate bonds	69,562		290		(8)		69,844
Asset-backed securities	22,990		147		(4)		23,133
Municipal bonds	6,340		3		(23)		6,320
Agency bonds	2,800		2		—		2,802
Non-current:
Corporate bonds	485,290		1,631		(773)		486,148
Asset-backed securities	60,418		346		(1)		60,763
Treasury bills	27,821		163		—		27,984
Agency bonds	16,124		40		—		16,164
Sovereign bonds	1,090		—		(1)		1,089
Municipal bonds	635		11		—		646
	$	779,727	$	2,990	$	(810)	$	781,907

Gross Unrealized Losses and Fair Values for Available-for-Sale Investments

The following table summarizes the Company’s gross unrealized losses and fair values for available-for-sale investments in an unrealized loss position as of October 3, 2021 (in thousands):

	Unrealized Loss Position For:
	Less than 12 Months				12 Months or Greater				Total
	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Corporate bonds	$	216,480	$	(781)	$	—	$	—	$	216,480	$	(781)
Municipal bonds	3,917		(23)		—		—		3,917		(23)
Asset-backed securities	3,732		(5)		—		—		3,732		(5)
Sovereign bonds	1,089		(1)		—		—		1,089		(1)
	$	225,218	$	(810)	$	—	$	—	$	225,218	$	(810)

Effective Maturity Dates of Available-for-Sale Investments

The following table presents the effective maturity dates of the Company’s available-for-sale investments as of October 3, 2021 (in thousands):

	<1 year		1-2 Years		2-3 Years		3-4 Years		4-5 Years		Total
Corporate bonds	$	69,844	$	192,354	$	151,615	$	94,993	$	47,186	$	555,992
Treasury bills	87,014		27,984		—		—		—		114,998
Asset-backed securities	23,133		41,115		6,217		13,431		—		83,896
Agency bonds	2,802		16,164		—		—		—		18,966
Municipal bonds	6,320		646		—		—		—		6,966
Sovereign bonds	—		—		—		—		1,089		1,089
	$	189,113	$	278,263	$	157,832	$	108,424	$	48,275	$	781,907

XML

Inventories (Tables)

9 Months Ended

Oct. 03, 2021

Inventory Disclosure [Abstract]

Schedule of Inventories

Inventories consisted of the following (in thousands):

	October 3, 2021		December 31, 2020
Raw materials	$	32,598	$	26,800
Work-in-process	2,975		4,780
Finished goods	45,597		29,250
	$	81,170	$	60,830

XML

Leases (Tables)

9 Months Ended

Oct. 03, 2021

Leases [Abstract]

Lessee, Operating Lease, Liability, Maturity

Future operating lease cash payments are as follows (in thousands):

Year Ended December 31,	Amount
Remainder of fiscal 2021	$	2,348
2022	8,221
2023	6,588
2024	3,526
2025	2,033
2026	1,297
Thereafter	5,160
	$	29,173

XML

Goodwill (Tables)

9 Months Ended

Oct. 03, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill

The changes in the carrying value of goodwill were as follows (in thousands):

Balance as of December 31, 2020	$	244,078
Foreign exchange rate changes	(2,279)
Balance as of October 3, 2021	$	241,799

XML

Intangible Assets (Tables)

9 Months Ended

Oct. 03, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets

Amortized intangible assets consisted of the following (in thousands):

	Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Distribution networks	$	38,060	$	38,060	$	—
Completed technologies	24,217		14,548		9,669
Customer relationships	10,578		7,700		2,878
Non-compete agreements	710		478		232
Trademarks	110		107		3
Balance as of October 3, 2021	$	73,675	$	60,893	$	12,782
	Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Distribution networks	$	38,060	$	38,060	$	—
Completed technologies	24,217		12,397		11,820
Customer relationships	10,578		7,160		3,418
Non-compete agreements	710		436		274
Trademarks	110		67		43
Balance as of December 31, 2020	$	73,675	$	58,120	$	15,555

Schedule of Intangible Assets, Future Amortization Expense

As of October 3, 2021, estimated future amortization expense related to intangible assets was as follows (in thousands):

Year Ended December 31,	Amount
Remainder of fiscal 2021	$	883
2022	3,286
2023	2,594
2024	2,080
2025	1,757
2026	1,452
Thereafter	730
	$	12,782

XML

Warranty Obligations (Tables)

9 Months Ended

Oct. 03, 2021

Product Warranties Disclosures [Abstract]

Changes in Warranty Obligations

The changes in the warranty obligation were as follows (in thousands):

Balance as of December 31, 2020	$	5,406
Provisions for warranties issued during the period	2,528
Fulfillment of warranty obligations	(2,517)
Balance as of October 3, 2021	$	5,417

XML

Derivative Instruments (Tables)

9 Months Ended

Oct. 03, 2021

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Outstanding Forward Contracts Table

The Company had the following outstanding forward contracts (in thousands):

	October 3, 2021			December 31, 2020
Currency	Notional Value	USD Equivalent		Notional Value	USD Equivalent
Derivatives Not Designated as Hedging Instruments:
Euro	38,500	$	44,687	50,000	$	61,342
Chinese Renminbi	55,069	8,500		—	—
Mexican Peso	120,000	5,823		155,000	7,776
Korean Won	6,770,000	5,714		6,925,000	6,377
Japanese Yen	600,000	5,405		600,000	5,808
British Pound	3,115	4,224		1,675	2,287
Hungarian Forint	1,235,000	3,992		1,330,000	4,494
Taiwanese Dollar	45,405	1,637		38,035	1,362
Singapore Dollar	1,800	1,328		1,465	1,110
Canadian Dollar	1,370	1,080		1,285	1,010

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

Information regarding the fair value of the outstanding forward contracts was as follows (in thousands):

	Asset Derivatives					Liability Derivatives
	Balance	Fair Value				Balance	Fair Value
	Sheet Location	October 3, 2021		December 31, 2020		Sheet Location	October 3, 2021		December 31, 2020
Derivatives Not Designated as Hedging Instruments:
Economic hedge forward contracts	Prepaid expenses and other current assets	$	129	$	265	Accrued expenses	$	88	$	38

Offsetting Assets

The following table presents the gross activity for all derivative assets and liabilities which were presented on a net basis on the Consolidated Balance Sheets due to the right of offset with each counterparty (in thousands):

Asset Derivatives					Liability Derivatives
	October 3, 2021		December 31, 2020			October 3, 2021		December 31, 2020
Gross amounts of recognized assets	$	129	$	265	Gross amounts of recognized liabilities	$	88	$	38
Gross amounts offset	—		—		Gross amounts offset	—		—
Net amount of assets presented	$	129	$	265	Net amount of liabilities presented	$	88	$	38

Derivative Instruments, Gain (Loss)

Information regarding the effect of derivative instruments on the consolidated financial statements was as follows (in thousands):

	Location in Financial Statements	Three-months Ended				Nine-months Ended
		October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
Derivatives Not Designated as Hedging Instruments:
Gains (losses) recognized in current operations	Foreign currency gain (loss)	$	1,529	$	(1,521)	$	3,676	$	(9,701)

XML

Revenue Recognition (Tables)

9 Months Ended

Oct. 03, 2021

Revenue from Contract with Customer [Abstract]

Revenue from External Customers by Geographic Areas

The following table summarizes disaggregated revenue information by geographic area based upon the customer's country of domicile (in thousands):

	Three-months Ended				Nine-months Ended
	October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
Americas	$	113,758	$	86,482	$	330,012	$	215,696
Europe	65,146		60,189		182,161		144,758
Greater China	65,813		77,292		163,757		135,593
Other Asia	40,131		27,110		117,103		91,358
	$	284,848	$	251,073	$	793,033	$	587,405

Revenue from External Customers by Products and Services

The following table summarizes disaggregated revenue information by revenue type (in thousands):

	Three-months Ended				Nine-months Ended
	October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
Standard products and services	$	212,567	$	174,797	$	669,215	$	486,458
Application-specific customer solutions	72,281		76,276		123,818		100,947
	$	284,848	$	251,073	$	793,033	$	587,405

Schedule of Allowance for Credit Loss Activity

The following table summarizes the allowance for credit losses activity for the nine-month period ended October 3, 2021 (in thousands):

Balance as of December 31, 2020	$	831
Increases to the allowance for credit losses	—
Write-offs, net of recoveries	(39)
Foreign exchange rate changes	—
Balance as of October 3, 2021	$	792

Deferred Revenue, by Arrangement, Disclosure

The following table summarizes the deferred revenue and customer deposits activity for the nine-month period ended October 3, 2021 (in thousands):

Balance as of December 31, 2020	$	21,274
Deferral of revenue billed in the current period, net of recognition	33,888
Recognition of revenue deferred in prior period	(17,130)
Foreign exchange rate changes	(189)
Balance as of October 3, 2021	$	37,843

XML

Stock-Based Compensation Expense (Tables)

9 Months Ended

Oct. 03, 2021

Share-based Payment Arrangement [Abstract]

Summary of Stock Option Activity

The following table summarizes the Company’s stock option activity for the nine-month period ended October 3, 2021:

	Shares (in thousands)	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of December 31, 2020	8,970	$	44.73
Granted	549	88.80
Exercised	(1,582)	37.70
Forfeited or expired	(225)	50.29
Outstanding as of October 3, 2021	7,712	$	49.15	6.79	$	252,476
Exercisable as of October 3, 2021	3,290	$	39.03	5.56	$	139,215
Options vested or expected to vest as of October 3, 2021 (1)	7,157	$	48.36	6.70	$	239,568

 (1) In addition to the vested options, the Company expects a portion of the unvested options to vest at some point in the future. Options expected to vest are calculated by applying an estimated forfeiture rate to the unvested options.

Weighted-Average Assumptions Used in Estimating Fair Values of Stock Options Granted

The fair values of stock options granted in each period presented were estimated using the following weighted-average assumptions:

	Three-months Ended				Nine-months Ended
	October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
Risk-free rate	1.4	%	—	%	1.3	%	1.6	%
Expected dividend yield	0.28	%	—	%	0.27	%	0.43	%
Expected volatility	39	%	—	%	39	%	37	%
Expected term (in years)	7.1		—		6.0		6.0

Schedule of Nonvested Restricted Stock Units Activity

The following table summarizes the Company's RSUs activity for the nine-month period ended October 3, 2021:

	Shares (in thousands)	Weighted-Average Grant Date Fair Value
Nonvested as of December 31, 2020	554	$	51.27
Granted	318	87.38
Vested	(15)	56.61
Forfeited or expired	(43)	56.49
Nonvested as of October 3, 2021	814	$	65.01

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs

The following table presents the stock-based compensation expense by caption for each period presented on the Consolidated Statements of Operations (in thousands):

	Three-months Ended				Nine-months Ended
	October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
Cost of revenue	$	366	$	324	$	965	$	1,041
Research, development, and engineering	3,091		2,815		10,158		10,582
Selling, general, and administrative	7,157		6,129		22,230		20,453
	$	10,614	$	9,268	$	33,353	$	32,076

XML

Income Taxes (Tables)

9 Months Ended

Oct. 03, 2021

Income Tax Disclosure [Abstract]

Reconciliation of United States Federal Statutory Corporate Tax Rate to Company's Effective Tax Rate, or Income Tax Provision

A reconciliation of the United States federal statutory corporate tax rate to the Company’s income tax expense, or effective tax rate, was as follows:

	Three-months Ended				Nine-months Ended
	October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
Income tax expense at U.S. federal statutory corporate tax rate	21	%	21	%	21	%	21	%
State income taxes, net of federal benefit	2	%	1	%	2	%	1	%
Foreign tax rate differential	(5)	%	(5)	%	(5)	%	(5)	%
Tax credit	(1)	%	(1)	%	(1)	%	(1)	%
Discrete tax benefit related to stock options	(4)	%	(4)	%	(4)	%	(9)	%
Discrete tax expense (benefit) related to tax return filings	(3)	%	—	%	(1)	%	3	%
Other	1	%	2	%	1	%	2	%
Income tax expense	11	%	14	%	13	%	12	%

XML

Weighted-Average Shares (Tables)

9 Months Ended

Oct. 03, 2021

Earnings Per Share [Abstract]

Calculation of Weighted-Average Shares

Weighted-average shares were calculated as follows (in thousands):

	Three-months Ended		Nine-months Ended
	October 3, 2021	September 27, 2020	October 3, 2021	September 27, 2020
Basic weighted-average common shares outstanding	176,812	173,943	176,572	172,881
Effect of dilutive equity awards	3,530	3,195	3,537	3,157
Weighted-average common and common-equivalent shares outstanding	180,342	177,138	180,109	176,038

XML

Restructuring Charges (Tables)

3 Months Ended

9 Months Ended

Sep. 27, 2020

Oct. 03, 2021

Restructuring and Related Activities [Abstract]

Schedule of Restructuring Charges

The following table summarizes the restructuring charges incurred in the three-month and nine-month periods ended September 27, 2020 (in thousands):

	Incurred in the Three-months Ended September 27, 2020		Incurred in the Nine-months Ended September 27, 2020
One-time termination benefits	$	(36)	$	10,350
Contract termination costs	104		4,099
Other associated costs	183		600
	$	251	$	15,049

Schedule of Activity in Restructuring Reserve

The following table summarizes the activity for the nine-month period ended October 3, 2021 in the Company’s restructuring reserve which is included in “Accrued expenses” on the Consolidated Balance Sheets (in thousands):

	One-time Termination Benefits		Contract Termination Costs		Other Associated Costs		Total
Balance as of December 31, 2020	$	1,624	$	750	$	15	$	2,389
Cash payments	(1,133)		(176)		(15)		(1,324)
Foreign exchange rate changes	—		(5)		—		(5)
Balance as of October 3, 2021	$	491	$	569	$	—	$	1,060

XML

Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Oct. 03, 2021	Dec. 31, 2020
Assets:
Money market instruments	$ 3,616	$ 2,464
Financial assets at fair value	781,907
Corporate Bonds
Assets:
Financial assets at fair value	555,992
Treasury Bills
Assets:
Financial assets at fair value	114,998
Asset-Backed Securities
Assets:
Financial assets at fair value	83,896
Agency Bonds
Assets:
Financial assets at fair value	18,966
Sovereign Bonds
Assets:
Financial assets at fair value	1,089
Municipal Bonds
Assets:
Financial assets at fair value	6,966
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair Value, Measurements, Recurring
Assets:
Money market instruments	3,616
Economic hedge forward contracts	0
Liabilities:
Economic hedge forward contracts	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair Value, Measurements, Recurring | Corporate Bonds
Assets:
Financial assets at fair value	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair Value, Measurements, Recurring | Treasury Bills
Assets:
Financial assets at fair value	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair Value, Measurements, Recurring | Asset-Backed Securities
Assets:
Financial assets at fair value	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair Value, Measurements, Recurring | Agency Bonds
Assets:
Financial assets at fair value	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair Value, Measurements, Recurring | Sovereign Bonds
Assets:
Financial assets at fair value	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair Value, Measurements, Recurring | Municipal Bonds
Assets:
Financial assets at fair value	0
Significant Other Observable Inputs (Level 2) | Fair Value, Measurements, Recurring
Assets:
Money market instruments	0
Economic hedge forward contracts	129
Liabilities:
Economic hedge forward contracts	88
Significant Other Observable Inputs (Level 2) | Fair Value, Measurements, Recurring | Corporate Bonds
Assets:
Financial assets at fair value	555,992
Significant Other Observable Inputs (Level 2) | Fair Value, Measurements, Recurring | Treasury Bills
Assets:
Financial assets at fair value	114,998
Significant Other Observable Inputs (Level 2) | Fair Value, Measurements, Recurring | Asset-Backed Securities
Assets:
Financial assets at fair value	83,896
Significant Other Observable Inputs (Level 2) | Fair Value, Measurements, Recurring | Agency Bonds
Assets:
Financial assets at fair value	18,966
Significant Other Observable Inputs (Level 2) | Fair Value, Measurements, Recurring | Sovereign Bonds
Assets:
Financial assets at fair value	1,089
Significant Other Observable Inputs (Level 2) | Fair Value, Measurements, Recurring | Municipal Bonds
Assets:
Financial assets at fair value	6,966
Unobservable Inputs (Level 3) | Fair Value, Measurements, Recurring
Assets:
Money market instruments	0
Economic hedge forward contracts	0
Liabilities:
Economic hedge forward contracts	0
Unobservable Inputs (Level 3) | Fair Value, Measurements, Recurring | Corporate Bonds
Assets:
Financial assets at fair value	0
Unobservable Inputs (Level 3) | Fair Value, Measurements, Recurring | Treasury Bills
Assets:
Financial assets at fair value	0
Unobservable Inputs (Level 3) | Fair Value, Measurements, Recurring | Asset-Backed Securities
Assets:
Financial assets at fair value	0
Unobservable Inputs (Level 3) | Fair Value, Measurements, Recurring | Agency Bonds
Assets:
Financial assets at fair value	0
Unobservable Inputs (Level 3) | Fair Value, Measurements, Recurring | Sovereign Bonds
Assets:
Financial assets at fair value	0
Unobservable Inputs (Level 3) | Fair Value, Measurements, Recurring | Municipal Bonds
Assets:
Financial assets at fair value	$ 0

XML

Fair Value Measurements (Details) - USD ($)	3 Months Ended			9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020	Jun. 28, 2020	Oct. 03, 2021	Sep. 27, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability	$ 0			$ 0		$ 0
Operating lease asset impairment charges			$ 2,534,000	0	$ 2,534,000
Intangible asset impairment charges	0	$ 0	19,571,000	0	$ 19,571,000
Restructuring Charges
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Operating lease asset impairment charges			$ 2,534,000
GVi Ventures, Inc. [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability, lower range	0			0
Contingent consideration liability, upper range	$ 2,500,000			$ 2,500,000

XML

Cash, Cash Equivalents, and Investments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020	Oct. 03, 2021	Sep. 27, 2020	Dec. 31, 2020
Cash and Cash Equivalents [Line Items]
Debt securities, available-for-sale, allowance for credit loss	$ 0		$ 0		$ 0
Credit loss on investments	0	$ 0	0	$ 160
Gross recoveries		0		85
Gross realized gains on sale of investments	19	787	87	3,613
Gross realized losses on sale of investments	0	$ 1	0	$ 22
Other Current Assets
Cash and Cash Equivalents [Line Items]
Accrued interest receivable	$ 3,481		$ 3,481		$ 1,560

XML

Cash, Cash Equivalents, and Investments - Components of Cash, Cash Equivalents, and Investments (Details) - USD ($) $ in Thousands	Oct. 03, 2021	Dec. 31, 2020
Debt Securities, Available-for-sale [Line Items]
Cash	$ 199,863	$ 266,609
Money market instruments	3,616	2,464
Cash and cash equivalents	203,479	269,073
Current investments	189,113	103,240
Non-current investments	592,794	395,125
Total	985,386	767,438
Treasury Bills
Debt Securities, Available-for-sale [Line Items]
Current investments	87,014	35,403
Long-term investments	27,984	96,458
Corporate Bonds
Debt Securities, Available-for-sale [Line Items]
Current investments	69,844	32,714
Long-term investments	486,148	203,428
Asset-Backed Securities
Debt Securities, Available-for-sale [Line Items]
Current investments	23,133	25,160
Long-term investments	60,763	67,058
Agency Bonds
Debt Securities, Available-for-sale [Line Items]
Current investments	2,802	0
Long-term investments	16,164	19,006
Municipal Bonds
Debt Securities, Available-for-sale [Line Items]
Current investments	6,320	1,303
Long-term investments	646	5,735
Sovereign Bonds
Debt Securities, Available-for-sale [Line Items]
Current investments	0	8,660
Long-term investments	$ 1,089	$ 3,440

XML

Cash, Cash Equivalents, and Investments - Summary of Available-for-Sale Investments (Details) $ in Thousands	Oct. 03, 2021 USD ($)
Debt Securities, Available-for-sale [Line Items]
Amortized cost	$ 779,727
Gross unrealized gains	2,990
Gross unrealized losses	(810)
Fair value	781,907
Agency Bonds
Debt Securities, Available-for-sale [Line Items]
Fair value	18,966
Agency Bonds | Short-Term Investments
Debt Securities, Available-for-sale [Line Items]
Amortized cost	2,800
Gross unrealized gains	2
Gross unrealized losses	0
Fair value	2,802
Agency Bonds | Long-Term Investments
Debt Securities, Available-for-sale [Line Items]
Amortized cost	16,124
Gross unrealized gains	40
Gross unrealized losses	0
Fair value	16,164
Treasury Bills
Debt Securities, Available-for-sale [Line Items]
Fair value	114,998
Treasury Bills | Short-Term Investments
Debt Securities, Available-for-sale [Line Items]
Amortized cost	86,657
Gross unrealized gains	357
Gross unrealized losses	0
Fair value	87,014
Treasury Bills | Long-Term Investments
Debt Securities, Available-for-sale [Line Items]
Amortized cost	27,821
Gross unrealized gains	163
Gross unrealized losses	0
Fair value	27,984
Corporate Bonds
Debt Securities, Available-for-sale [Line Items]
Fair value	555,992
Corporate Bonds | Short-Term Investments
Debt Securities, Available-for-sale [Line Items]
Amortized cost	69,562
Gross unrealized gains	290
Gross unrealized losses	(8)
Fair value	69,844
Corporate Bonds | Long-Term Investments
Debt Securities, Available-for-sale [Line Items]
Amortized cost	485,290
Gross unrealized gains	1,631
Gross unrealized losses	(773)
Fair value	486,148
Asset-Backed Securities
Debt Securities, Available-for-sale [Line Items]
Fair value	83,896
Asset-Backed Securities | Short-Term Investments
Debt Securities, Available-for-sale [Line Items]
Amortized cost	22,990
Gross unrealized gains	147
Gross unrealized losses	(4)
Fair value	23,133
Asset-Backed Securities | Long-Term Investments
Debt Securities, Available-for-sale [Line Items]
Amortized cost	60,418
Gross unrealized gains	346
Gross unrealized losses	(1)
Fair value	60,763
Sovereign Bonds
Debt Securities, Available-for-sale [Line Items]
Fair value	1,089
Sovereign Bonds | Long-Term Investments
Debt Securities, Available-for-sale [Line Items]
Amortized cost	1,090
Gross unrealized gains	0
Gross unrealized losses	(1)
Fair value	1,089
Municipal Bonds
Debt Securities, Available-for-sale [Line Items]
Fair value	6,966
Municipal Bonds | Short-Term Investments
Debt Securities, Available-for-sale [Line Items]
Amortized cost	6,340
Gross unrealized gains	3
Gross unrealized losses	(23)
Fair value	6,320
Municipal Bonds | Long-Term Investments
Debt Securities, Available-for-sale [Line Items]
Amortized cost	635
Gross unrealized gains	11
Gross unrealized losses	0
Fair value	$ 646

XML

Cash, Cash Equivalents, and Investments - Gross Unrealized Losses and Fair Values for Available-for-Sale Investments (Details) $ in Thousands	Oct. 03, 2021 USD ($)
Debt Securities, Available-for-sale [Line Items]
Fair value, less than 12 months	$ 225,218
Unrealized losses, less than 12 months	(810)
Fair value, 12 months or greater	0
Unrealized losses, 12 months or greater	0
Total fair value	225,218
Total Unrealized Losses	(810)
Corporate Bonds
Debt Securities, Available-for-sale [Line Items]
Fair value, less than 12 months	216,480
Unrealized losses, less than 12 months	(781)
Fair value, 12 months or greater	0
Unrealized losses, 12 months or greater	0
Total fair value	216,480
Total Unrealized Losses	(781)
Municipal Bonds
Debt Securities, Available-for-sale [Line Items]
Fair value, less than 12 months	3,917
Unrealized losses, less than 12 months	(23)
Fair value, 12 months or greater	0
Unrealized losses, 12 months or greater	0
Total fair value	3,917
Total Unrealized Losses	(23)
Asset-Backed Securities
Debt Securities, Available-for-sale [Line Items]
Fair value, less than 12 months	3,732
Unrealized losses, less than 12 months	(5)
Fair value, 12 months or greater	0
Unrealized losses, 12 months or greater	0
Total fair value	3,732
Total Unrealized Losses	(5)
Sovereign Bonds
Debt Securities, Available-for-sale [Line Items]
Fair value, less than 12 months	1,089
Unrealized losses, less than 12 months	(1)
Fair value, 12 months or greater	0
Unrealized losses, 12 months or greater	0
Total fair value	1,089
Total Unrealized Losses	$ (1)

XML

Cash, Cash Equivalents, and Investments - Effective Maturity Dates of Available-for-Sale Investments (Details) $ in Thousands	Oct. 03, 2021 USD ($)
Debt Securities, Available-for-sale [Line Items]
less than 1 year	$ 189,113
1-2 Years	278,263
2-3 Years	157,832
3-4 Years	108,424
4-5 Years	48,275
Fair value	781,907
Corporate Bonds
Debt Securities, Available-for-sale [Line Items]
less than 1 year	69,844
1-2 Years	192,354
2-3 Years	151,615
3-4 Years	94,993
4-5 Years	47,186
Fair value	555,992
Treasury Bills
Debt Securities, Available-for-sale [Line Items]
less than 1 year	87,014
1-2 Years	27,984
2-3 Years	0
3-4 Years	0
4-5 Years	0
Fair value	114,998
Asset-Backed Securities
Debt Securities, Available-for-sale [Line Items]
less than 1 year	23,133
1-2 Years	41,115
2-3 Years	6,217
3-4 Years	13,431
4-5 Years	0
Fair value	83,896
Agency Bonds
Debt Securities, Available-for-sale [Line Items]
less than 1 year	2,802
1-2 Years	16,164
2-3 Years	0
3-4 Years	0
4-5 Years	0
Fair value	18,966
Sovereign Bonds
Debt Securities, Available-for-sale [Line Items]
less than 1 year	0
1-2 Years	0
2-3 Years	0
3-4 Years	0
4-5 Years	1,089
Fair value	1,089
Municipal Bonds
Debt Securities, Available-for-sale [Line Items]
less than 1 year	6,320
1-2 Years	646
2-3 Years	0
3-4 Years	0
4-5 Years	0
Fair value	$ 6,966

XML

Inventories - Schedule of Inventories (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020	Oct. 03, 2021	Sep. 27, 2020	Dec. 31, 2020
Inventory Disclosure [Abstract]
Raw materials	$ 32,598		$ 32,598		$ 26,800
Work-in-process	2,975		2,975		4,780
Finished goods	45,597		45,597		29,250
Inventories	81,170		81,170		$ 60,830
Excess and obsolete inventory charges	$ 304	$ 603	$ 2,120	$ 9,386

XML

Leases - Narrative (Details) $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Oct. 03, 2021 USD ($)	Sep. 27, 2020 USD ($)	Jun. 28, 2020 USD ($)	Oct. 03, 2021 USD ($)	Sep. 27, 2020 USD ($)	Dec. 31, 2020 USD ($) Employees
Lessor, Lease, Description [Line Items]
Operating lease, cost	$ 2,068	$ 2,047		$ 6,091	$ 6,100
Operating lease, payments	2,079	2,041		6,154	5,995
Lease, cost	36	$ 22		114	84
Operating lease liability	$ 26,811			$ 26,811		$ 26,230
Weighted average discount rate	3.50%			3.50%		4.00%
Weighted average remaining lease term	5 years 2 months 12 days			5 years 2 months 12 days		5 years 1 month 6 days
Number of leases offices that were closed | Employees						11
Carrying value operating lease right-of-use assets impaired			$ 0
Operating lease asset impairment charges			$ 2,534	$ 0	$ 2,534
Contract termination costs
Lessor, Lease, Description [Line Items]
Operating lease liability	$ 2,019			$ 2,019		$ 2,877

XML

Leases - Future Minimum Lease Payment Obligations Under Operating Leases (Details) $ in Thousands	Oct. 03, 2021 USD ($)
Leases [Abstract]
Remainder of fiscal 2021	$ 2,348
2022	8,221
2023	6,588
2024	3,526
2025	2,033
2026	1,297
Thereafter	5,160
Total	$ 29,173

XML

Goodwill (Details) $ in Thousands	9 Months Ended
	Oct. 03, 2021 USD ($)
Goodwill [Roll Forward]
Balance as of December 31, 2020	$ 244,078
Foreign exchange rate changes	(2,279)
Balance as of October 3, 2021	$ 241,799

XML

Intangible Assets (Details) - USD ($) $ in Thousands	Oct. 03, 2021	Dec. 31, 2020	May 26, 2020
Distribution Rights, Developed Technology Rights, Customer Contracts And Relationships, Other Intangible Assets, And Trademarks
Gross Carrying Value	$ 73,675	$ 73,675
Accumulated Amortization	60,893	58,120
Net Carrying Value	12,782	15,555
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Net Carrying Value	12,782	15,555
Distribution networks
Distribution Rights, Developed Technology Rights, Customer Contracts And Relationships, Other Intangible Assets, And Trademarks
Gross Carrying Value	38,060	38,060
Accumulated Amortization	38,060	38,060
Net Carrying Value	0	0
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Net Carrying Value	0	0
Completed technologies
Distribution Rights, Developed Technology Rights, Customer Contracts And Relationships, Other Intangible Assets, And Trademarks
Gross Carrying Value	24,217	24,217
Accumulated Amortization	14,548	12,397
Net Carrying Value	9,669	11,820
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Net Carrying Value	9,669	11,820
Customer relationships
Distribution Rights, Developed Technology Rights, Customer Contracts And Relationships, Other Intangible Assets, And Trademarks
Gross Carrying Value	10,578	10,578
Accumulated Amortization	7,700	7,160
Net Carrying Value	2,878	3,418
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Net Carrying Value	2,878	3,418
Customer relationships | EnShape GmbH
Distribution Rights, Developed Technology Rights, Customer Contracts And Relationships, Other Intangible Assets, And Trademarks
Accumulated Amortization			$ 228
Non-compete agreements
Distribution Rights, Developed Technology Rights, Customer Contracts And Relationships, Other Intangible Assets, And Trademarks
Gross Carrying Value	710	710
Accumulated Amortization	478	436
Net Carrying Value	232	274
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Net Carrying Value	232	274
Trademarks
Distribution Rights, Developed Technology Rights, Customer Contracts And Relationships, Other Intangible Assets, And Trademarks
Gross Carrying Value	110	110
Accumulated Amortization	107	67
Net Carrying Value	3	43
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Net Carrying Value	3	$ 43
Indefinite-lived intangible asset excluding in-process technologies
Distribution Rights, Developed Technology Rights, Customer Contracts And Relationships, Other Intangible Assets, And Trademarks
Net Carrying Value	12,782
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Remainder of fiscal 2021	883
2022	3,286
2023	2,594
2024	2,080
2025	1,757
2026	1,452
Thereafter	730
Net Carrying Value	$ 12,782

XML

Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020	Jun. 28, 2020	Oct. 03, 2021	Sep. 27, 2020	Dec. 31, 2020	May 26, 2020
Distribution Rights, Developed Technology Rights, Customer Contracts And Relationships, Other Intangible Assets, And Trademarks
Intangible asset impairment charges	$ 0	$ 0	$ 19,571	$ 0	$ 19,571
Accumulated amortization	60,893			60,893		$ 58,120
Distribution networks
Distribution Rights, Developed Technology Rights, Customer Contracts And Relationships, Other Intangible Assets, And Trademarks
Accumulated amortization	38,060			38,060		38,060
Completed technologies
Distribution Rights, Developed Technology Rights, Customer Contracts And Relationships, Other Intangible Assets, And Trademarks
Accumulated amortization	14,548			14,548		12,397
Completed technologies | Sualab
Distribution Rights, Developed Technology Rights, Customer Contracts And Relationships, Other Intangible Assets, And Trademarks
Intangible asset impairment charges			10,070
Customer relationships
Distribution Rights, Developed Technology Rights, Customer Contracts And Relationships, Other Intangible Assets, And Trademarks
Accumulated amortization	7,700			7,700		7,160
Customer relationships | EnShape GmbH
Distribution Rights, Developed Technology Rights, Customer Contracts And Relationships, Other Intangible Assets, And Trademarks
Intangible asset impairment charges			219
Intangible assets acquired			0				$ 447
Accumulated amortization							$ 228
Customer relationships | Sualab
Distribution Rights, Developed Technology Rights, Customer Contracts And Relationships, Other Intangible Assets, And Trademarks
Intangible asset impairment charges			3,382
Non-compete agreements
Distribution Rights, Developed Technology Rights, Customer Contracts And Relationships, Other Intangible Assets, And Trademarks
Accumulated amortization	478			478		436
Trademarks
Distribution Rights, Developed Technology Rights, Customer Contracts And Relationships, Other Intangible Assets, And Trademarks
Accumulated amortization	$ 107			$ 107		$ 67
In-process technologies | Sualab
Distribution Rights, Developed Technology Rights, Customer Contracts And Relationships, Other Intangible Assets, And Trademarks
Intangible asset impairment charges			$ 5,900

XML

Warranty Obligations - Changes in Warranty Obligations (Detail) $ in Thousands	9 Months Ended
	Oct. 03, 2021 USD ($)
Movement in Standard Product Warranty Accrual [Roll Forward]
Beginning balance	$ 5,406
Provisions for warranties issued during the period	2,528
Fulfillment of warranty obligations	(2,517)
Ending balance	$ 5,417

XML

Derivative Instruments (Details)	9 Months Ended
	Oct. 03, 2021
Not Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Remaining maturity of foreign currency derivatives (up to)	95 days

XML

Derivative Instruments - Outstanding Forward Contracts Table (Details) - Not Designated as Hedging Instrument € in Thousands, ₩ in Thousands, ¥ in Thousands, ¥ in Thousands, £ in Thousands, Ft in Thousands, $ in Thousands, $ in Thousands, $ in Thousands, $ in Thousands, $ in Thousands	Oct. 03, 2021 EUR (€)	Oct. 03, 2021 USD ($)	Oct. 03, 2021 CNY (¥)	Oct. 03, 2021 MXN ($)	Oct. 03, 2021 KRW (₩)	Oct. 03, 2021 JPY (¥)	Oct. 03, 2021 GBP (£)	Oct. 03, 2021 HUF (Ft)	Oct. 03, 2021 TWD ($)	Oct. 03, 2021 SGD ($)	Oct. 03, 2021 CAD ($)	Dec. 31, 2020 EUR (€)	Dec. 31, 2020 USD ($)	Dec. 31, 2020 CNY (¥)	Dec. 31, 2020 MXN ($)	Dec. 31, 2020 KRW (₩)	Dec. 31, 2020 JPY (¥)	Dec. 31, 2020 GBP (£)	Dec. 31, 2020 HUF (Ft)	Dec. 31, 2020 TWD ($)	Dec. 31, 2020 SGD ($)	Dec. 31, 2020 CAD ($)
Euro Member Countries, Euro
Derivative [Line Items]
Outstanding forward contracts	€ 38,500	$ 44,687										€ 50,000	$ 61,342
China, Yuan Renminbi
Derivative [Line Items]
Outstanding forward contracts		8,500	¥ 55,069										0	¥ 0
Mexico, Pesos
Derivative [Line Items]
Outstanding forward contracts		5,823		$ 120,000									7,776		$ 155,000
Japanese Yen
Derivative [Line Items]
Outstanding forward contracts		5,405				¥ 600,000							5,808				¥ 600,000
Hungary, Forint
Derivative [Line Items]
Outstanding forward contracts		3,992						Ft 1,235,000					4,494						Ft 1,330,000
United Kingdom, Pounds
Derivative [Line Items]
Outstanding forward contracts		4,224					£ 3,115						2,287					£ 1,675
Taiwanese Dollar
Derivative [Line Items]
Outstanding forward contracts		1,637							$ 45,405				1,362							$ 38,035
Canada, Dollars
Derivative [Line Items]
Outstanding forward contracts		1,080									$ 1,370		1,010									$ 1,285
Singapore, Dollars
Derivative [Line Items]
Outstanding forward contracts		1,328								$ 1,800			1,110								$ 1,465
Korean Won
Derivative [Line Items]
Outstanding forward contracts		$ 5,714			₩ 6,770,000								$ 6,377			₩ 6,925,000

XML

Derivative Instruments - Schedule of Derivative Instruments in Statement of Financial Position, Fair Value (Details) - USD ($) $ in Thousands	Oct. 03, 2021	Dec. 31, 2020
Derivatives, Fair Value [Line Items]
Derivative asset	$ 129	$ 265
Derivative liability	88	38
Not Designated as Hedging Instrument | Prepaid Expenses and Other Current Assets
Derivatives, Fair Value [Line Items]
Derivative asset	129	265
Not Designated as Hedging Instrument | Accrued Expenses
Derivatives, Fair Value [Line Items]
Derivative liability	$ 88	$ 38

XML

Derivative Instruments - Offsetting Assets (Details) - USD ($) $ in Thousands	Oct. 03, 2021	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Gross amounts of recognized assets	$ 129	$ 265
Gross amounts offset	0	0
Net amount of assets presented	129	265
Gross amounts of recognized liabilities	88	38
Gross amounts offset	0	0
Net amount of liabilities presented	$ 88	$ 38

XML

Derivative Instruments - Derivative Instruments, Gain (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020	Oct. 03, 2021	Sep. 27, 2020
Not Designated as Hedging Instrument | Foreign Currency Gain (Loss)
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) recognized in current operations	$ 1,529	$ (1,521)	$ 3,676	$ (9,701)

XML

Revenue Recognition - Revenue Disaggregated by Geography (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020	Oct. 03, 2021	Sep. 27, 2020
Disaggregation of Revenue [Line Items]
Revenue	$ 284,848	$ 251,073	$ 793,033	$ 587,405
Americas
Disaggregation of Revenue [Line Items]
Revenue	113,758	86,482	330,012	215,696
Europe
Disaggregation of Revenue [Line Items]
Revenue	65,146	60,189	182,161	144,758
Greater China
Disaggregation of Revenue [Line Items]
Revenue	65,813	77,292	163,757	135,593
Other Asia
Disaggregation of Revenue [Line Items]
Revenue	$ 40,131	$ 27,110	$ 117,103	$ 91,358

XML

Revenue Recognition - Revenue Disaggregated by Products and Services (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020	Oct. 03, 2021	Sep. 27, 2020
Revenue from External Customer [Line Items]
Revenue	$ 284,848	$ 251,073	$ 793,033	$ 587,405
Standard products and services
Revenue from External Customer [Line Items]
Revenue	212,567	174,797	669,215	486,458
Application-specific customer solutions
Revenue from External Customer [Line Items]
Revenue	$ 72,281	$ 76,276	$ 123,818	$ 100,947

XML

Revenue Recognition - Additional Information (Details) - USD ($) $ in Thousands	Oct. 03, 2021	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Costs to fulfill contract	$ 13,308	$ 6,846

XML

Revenue Recognition - Schedule of Allowance for Credit Loss (Details) $ in Thousands	9 Months Ended
	Oct. 03, 2021 USD ($)
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance as of December 31, 2020	$ 831
Increases to the allowance for credit losses	0
Write-offs, net of recoveries	(39)
Foreign exchange rate changes	0
Balance as of October 3, 2021	$ 792

XML

Revenue Recognition - Deferred Revenue Activity (Details) $ in Thousands	9 Months Ended
	Oct. 03, 2021 USD ($)
Movement in Deferred Revenue [Roll Forward]
Balance as of December 31, 2020	$ 21,274
Deferral of revenue billed in the current period, net of recognition	33,888
Recognition of revenue deferred in prior period	(17,130)
Foreign exchange rate changes	(189)
Balance as of October 3, 2021	$ 37,843

XML

Stock-Based Compensation Expense (Details)	3 Months Ended		9 Months Ended
	Oct. 03, 2021 USD ($) group $ / shares shares	Sep. 27, 2020 USD ($) $ / shares shares	Oct. 03, 2021 USD ($) group $ / shares shares	Sep. 27, 2020 USD ($) $ / shares shares	Dec. 31, 2020 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted (in shares) | shares		0
Weighted-average grant-date fair values, in dollars per share | $ / shares	$ 35.64		$ 33.78	$ 18.52
Total intrinsic value	$ 21,415,000	$ 62,787,000	$ 75,363,000	$ 116,600,000
Total fair values of stock options vest	$ 1,498,000	1,331,000	$ 38,928,000	39,282,000
Groups within the employee population | group	2		2
Estimated annual forfeiture rate for unvested options for senior management	8.00%		8.00%
Estimated annual forfeiture rate for unvested options for all other employees	12.00%		12.00%
Increase (decrease) to compensation expense			$ 255,000	1,787,000
Unrecognized compensation expense	$ 56,579,000		$ 56,579,000
Weighted average period to be recognized			1 year 7 months 6 days
Stock-based compensation expense	10,614,000	9,268,000	$ 33,353,000	32,076,000
Tax benefit from compensation expense	1,637,000	1,524,000	5,101,000	$ 5,365,000
Credits relating to grants cancelled		$ 1,401,000
Recognized period costs capitalized	$ 0		$ 0		$ 0
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for grant under stock option plans (in shares) | shares	15,661,000		15,661,000
Expiration period from grant day			10 years
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period for stock option plans			3 years
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in dollars per share) | $ / shares	$ 86.34	$ 67.14	$ 87.38	$ 51.73
Vested (in shares) | shares	0	0	15,000	0
Minimum | General Stock Option Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period for stock option plans			4 years
Maximum | General Stock Option Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period for stock option plans			5 years

XML

Stock-Based Compensation Expense - Summary of Stock Option Activity (Details) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended
	Oct. 03, 2021 USD ($) $ / shares shares
Shares (in thousands)
Outstanding, shares | shares	8,970
Granted, shares | shares	549
Exercised, shares | shares	(1,582)
Forfeited or expired, shares | shares	(225)
Outstanding, shares | shares	7,712
Exercisable as of reporting date, shares | shares	3,290
Options vested or expected to vest as of reporting date, shares | shares	7,157
Weighted- Average Exercise Price
Outstanding, in dollars per share | $ / shares	$ 44.73
Granted, in dollars per share | $ / shares	88.80
Exercised, in dollars per share | $ / shares	37.70
Forfeited or expired, in dollars per share | $ / shares	50.29
Outstanding, in dollars per share | $ / shares	49.15
Exercisable as of reporting date, Weighted-Average Exercise Price, in dollars per share | $ / shares	39.03
Vested and expected to vest, outstanding, in dollars per share | $ / shares	$ 48.36
Weighted- Average Remaining Contractual Term (in years)
Outstanding, in years	6 years 9 months 14 days
Exercisable, in years	5 years 6 months 21 days
Options vested or expected to vest, in years	6 years 8 months 12 days
Aggregate Intrinsic Value (in thousands)
Outstanding, in dollars | $	$ 252,476
Exercisable, in dollars | $	139,215
Options vested or expected to vest, in dollars | $	$ 239,568

XML

Stock-Based Compensation Expense - Weighted-Average Assumptions Used in Estimating Fair Values of Stock Options Granted (Details)	3 Months Ended		9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020	Oct. 03, 2021	Sep. 27, 2020
Share-based Payment Arrangement [Abstract]
Risk-free rate	1.40%	0.00%	1.30%	1.60%
Expected dividend yield	0.28%	0.00%	0.27%	0.43%
Expected volatility	39.00%	0.00%	39.00%	37.00%
Expected term (in years)	7 years 1 month 6 days	0 years	6 years	6 years

XML

Stock-Based Compensation Expense Stock-Based Compensation Expense - Schedule of Restricted Stock Units (Details) - Restricted Stock Units (RSUs) - $ / shares	3 Months Ended		9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020	Oct. 03, 2021	Sep. 27, 2020
Shares (in thousands)
Nonvested as of December 31, 2019 (in shares)			554,000
Granted (in shares)			318,000
Vested (in shares)	0	0	15,000	0
Forfeited or expired (in shares)			(43,000)
Nonvested as of March 29, 2020 (in shares)	814,000		814,000
Weighted-Average Grant Date Fair Value
Nonvested as of December 31, 2019 (in dollars per share)			$ 51.27
Granted (in dollars per share)	$ 86.34	$ 67.14	87.38	$ 51.73
Vested (in dollars per share)			56.61
Forfeited or expired (in dollars per share)			56.49
Nonvested as of March 29, 2020 (in dollars per share)	$ 65.01		$ 65.01

XML

Stock-Based Compensation Expense - Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020	Oct. 03, 2021	Sep. 27, 2020
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 10,614	$ 9,268	$ 33,353	$ 32,076
Cost of Revenue
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	366	324	965	1,041
Research, Development, and Engineering Expenses
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	3,091	2,815	10,158	10,582
Selling, General, and Administrative
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 7,157	$ 6,129	$ 22,230	$ 20,453

XML

Stock Repurchase Program (Details) - USD ($) shares in Thousands	3 Months Ended	9 Months Ended
	Oct. 03, 2021	Oct. 03, 2021	Sep. 27, 2020	Mar. 12, 2020	Oct. 29, 2018
Equity, Class of Treasury Stock [Line Items]
Stock repurchased during period, value	$ 27,417,000	$ 48,294,000	$ 51,036,000
Remaining authorized repurchase amount	$ 30,357,000	$ 30,357,000
Repurchase Program October 2018
Equity, Class of Treasury Stock [Line Items]
Authorized common stock to be repurchased					$ 200,000,000
Repurchase of common stock (in shares)		3,398
Stock repurchased during period, value		$ 169,643,000
Shares repurchased at cost (in shares)		581	1,215
Shares repurchased at cost		$ 48,294,000	$ 51,036,000
Repurchase Program March 2020
Equity, Class of Treasury Stock [Line Items]
Authorized common stock to be repurchased				$ 200,000,000

XML

Income Taxes - Reconciliation of United States Federal Statutory Corporate Tax Rate to Company's Effective Tax Rate, or Income Tax Provision (Details)	3 Months Ended		9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020	Oct. 03, 2021	Sep. 27, 2020
Income Tax Disclosure [Abstract]
Income tax expense at U.S. federal statutory corporate tax rate	21.00%	21.00%	21.00%	21.00%
State income taxes, net of federal benefit	2.00%	1.00%	2.00%	1.00%
Foreign tax rate differential	(5.00%)	(5.00%)	(5.00%)	(5.00%)
Tax credit	(1.00%)	(1.00%)	(1.00%)	(1.00%)
Discrete tax benefit related to stock options	(4.00%)	(4.00%)	(4.00%)	(9.00%)
Discrete tax expense (benefit) related to tax return filings	(3.00%)	0.00%	(1.00%)	3.00%
Other	1.00%	2.00%	1.00%	2.00%
Income tax expense	11.00%	14.00%	13.00%	12.00%

XML

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020	Oct. 03, 2021	Sep. 27, 2020	Dec. 31, 2020
Income Tax Contingency [Line Items]
Discrete tax benefit related to stock options	4.00%	4.00%	4.00%	9.00%
Discrete tax expense (benefit) related to tax return filings	(3.00%)	0.00%	(1.00%)	3.00%
Effective tax rate excluding discrete items (as a percent)	18.00%	18.00%	18.00%	18.00%
Decrease in reserves for income taxes, net of deferred tax benefit			$ 495
Interest and penalties included in reserve			450
Liability for uncertain tax positions	$ 15,833		15,833
Reserve for income taxes classified as a noncurrent iability	14,805		14,805		$ 14,257
Increase to non-current deferred tax liability			$ 1,028
Amount of reserves released	$ 648
Income tax expense at U.S. federal statutory corporate tax rate	21.00%	21.00%	21.00%	21.00%
Decrease in effective tax rate	5.00%	5.00%	5.00%	5.00%
Tax years open to examination by Internal Revenue Service			2017 through 2020
Tax years open to examination by various taxing authorities for other entities			2016 through 2020
Foreign Tax Authority | Revenue Commissioners, Ireland
Income Tax Contingency [Line Items]
Income tax expense at U.S. federal statutory corporate tax rate	12.50%
Foreign Tax Authority | State Administration of Taxation, China
Income Tax Contingency [Line Items]
Income tax expense at U.S. federal statutory corporate tax rate	25.00%
Foreign Tax Authority | KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF
Income Tax Contingency [Line Items]
Income tax expense at U.S. federal statutory corporate tax rate	25.00%
Domestic Tax Authority
Income Tax Contingency [Line Items]
Income tax expense at U.S. federal statutory corporate tax rate	21.00%

XML

Weighted-Average Shares - Calculation of Weighted-Average Shares (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020	Oct. 03, 2021	Sep. 27, 2020
Earnings Per Share [Abstract]
Basic weighted-average common shares outstanding (in shares)	176,812	173,943	176,572	172,881
Effect of dilutive equity awards (in shares)	3,530	3,195	3,537	3,157
Weighted-average common and common-equivalent shares outstanding (in shares)	180,342	177,138	180,109	176,038

XML

Weighted-Average Shares (Details) - shares	3 Months Ended		9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020	Oct. 03, 2021	Sep. 27, 2020
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Anti-dilutive securities excluded from computation of earnings per share (shares)	586,000	1,416,000	655,000	5,540,000
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Anti-dilutive securities excluded from computation of earnings per share (shares)	1,000	3,000	1,000	2,000

XML

Restructuring Charges - Narrative (Details) $ in Thousands	3 Months Ended			9 Months Ended
	Oct. 03, 2021 USD ($)	Sep. 27, 2020 USD ($)	Jun. 28, 2020 Employees	Oct. 03, 2021 USD ($)	Sep. 27, 2020 USD ($)	May 26, 2020
Restructuring and Related Activities [Abstract]
Workforce reduction (as a percent)						8.00%
Restructuring charges | $	$ 0	$ 251		$ 0	$ 15,049
Number of employees terminated | Employees			181

XML

Restructuring Charges - Activity in Restructuring Reserve (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020	Oct. 03, 2021	Sep. 27, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 0	$ 251	$ 0	$ 15,049
Accrued Expenses
Restructuring Reserve [Roll Forward]
Balance at beginning of period			2,389
Cash payments			(1,324)
Foreign exchange rate changes			(5)
Balance at end of period	1,060		1,060
One-time Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges		(36)		10,350
One-time Termination Benefits | Accrued Expenses
Restructuring Reserve [Roll Forward]
Balance at beginning of period			1,624
Cash payments			(1,133)
Foreign exchange rate changes			0
Balance at end of period	491		491
Contract Termination Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges		104		4,099
Contract Termination Costs | Accrued Expenses
Restructuring Reserve [Roll Forward]
Balance at beginning of period			750
Cash payments			(176)
Foreign exchange rate changes			(5)
Balance at end of period	569		569
Other Associated Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 183		$ 600
Other Associated Costs | Accrued Expenses
Restructuring Reserve [Roll Forward]
Balance at beginning of period			15
Cash payments			(15)
Foreign exchange rate changes			0
Balance at end of period	$ 0		$ 0

XML

Subsequent Events (Details)	Nov. 04, 2021 $ / shares
Subsequent Event
Subsequent Event [Line Items]
Dividends (in dollars per share)	$ 0.065